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preferentially associated with the most upregulated genes, suggesting that acetyl-group transfer plays an
important role in gene activation. Overall, our data reveal direct transfer of acetate between histone lysine
residues to facilitate rapid transcriptional induction, an exchange that may be critical during changes in
nutrient availability.Since ACSS2 does not have known DNA- or histone-binding domains, we hypothesize
that it associates with chromatin indirectly through other transcription factors or chromatin modifying
enzymes. We performed immunoprecipitation experiments coupled to mass spectrometry in neuronal cell
lines and mouse models and identified nuclear accumbens associated 1 (NACC1) as a novel interactor.
We determined nuclear localization of both ACSS2 and NACC1 in differentiated cells through proteomics
experiments. Moreover, we have found ACSS2 and NACC1 chromatin-bound during differentiation and
enriched near genes of cell-cell adherens, cytoplasmic, and membrane, which are important in
differentiation and formation of neuronal processes. Our findings highlight a potential mechanism for
ACSS2 recruitment to during critical metabolic changes such as neuronal differentiation.
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ABSTRACT
UNDERSTANDING THE ROLE OF NUCLEAR ACETYL-COA SYNTHETASE 2 IN
MAINTAINING HISTONE ACETYLATION
Mariel Mendoza
Shelley L. Berger
Benjamin A. Garcia

Histone acetylation is governed by nuclear acetyl-CoA pools generated in part from local
acetate by metabolic enzyme acetyl-CoA synthetase 2 (ACSS2). We hypothesize that during gene
activation, a local transfer of intact acetate occurs via sequential action of epigenetic and metabolic
enzymes. Using stable isotope labeling, we detect transfer between histone acetylation sites both
in vitro using purified mammalian enzymes and in vivo using quiescence exit in Saccharomyces
cerevisiae as a change-of-state model. We show that Acs2, the yeast orthologue of ACSS2, is
recruited to chromatin during quiescence exit, and observe dynamic histone acetylation changes
proximal to Acs2 peaks. We find that Acs2 is preferentially associated with the most upregulated
genes, suggesting that acetyl-group transfer plays an important role in gene activation. Overall, our
data reveal direct transfer of acetate between histone lysine residues to facilitate rapid
transcriptional induction, an exchange that may be critical during changes in nutrient availability.
Since ACSS2 does not have known DNA- or histone-binding domains, we hypothesize that
it associates with chromatin indirectly through other transcription factors or chromatin modifying
enzymes. We performed immunoprecipitation experiments coupled to mass spectrometry in
neuronal cell lines and mouse models and identified nuclear accumbens associated 1 (NACC1) as
a novel interactor. We determined nuclear localization of both ACSS2 and NACC1 in differentiated
cells through proteomics experiments. Moreover, we have found ACSS2 and NACC1 chromatinbound during differentiation and enriched near genes of cell-cell adherens, cytoplasmic, and
membrane, which are important in differentiation and formation of neuronal processes. Our findings
vi

highlight a potential mechanism for ACSS2 recruitment to during critical metabolic changes such
as neuronal differentiation.
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CHAPTER 1 Introduction
1.1 Overview of epigenetics and histone modifications
Since its introduction in 1942 by C.H. Waddington, the field of epigenetics has drastically
accelerated over the past several decades (Waddington 2012; Allis and Jenuwein 2016).
Epigenetics is defined as heritable changes in gene expression patterns without altering the DNA
sequence (Berger et al. 2009). Cellular differentiation is an example of biological processes tightly
regulated by epigenetic mechanisms, as cells that contain identical genomes can generate diverse
cell types and functions. Waddington’s classical epigenetics landscape reflects this process,
wherein cells can take specific paths leading to distinct outcomes and fate (Figure 1.1) (Waddington
and Kacser 1957).

Figure 1.1 Waddington’s epigenetics landscape illustrating cell fate commitment.
The cell (represented in the diagram as a ball) can take different trajectories to make its way to the
bottom of the valley, and this reflects the different outcomes or cell fate. Figure adapted from
(Waddington and Kacser 1957).

A huge part of epigenetics research is centered on the study of covalent and noncovalent
modifications on DNA and histone proteins, and the mechanisms by which these marks affect
1

chromatin functions and cell fates (Goldberg, Allis, and Bernstein 2007). Histone modifications are
key epigenetic regulators, since deposition of specific marks determine gene expression. DNA is
tightly wrapped around histone proteins, in units known as nucleosomes. A nucleosome consists
of 147 bp of DNA associated with an octomeric core of histone proteins: two copies each of histone
H2A, H2B, H3, and H4 (Handy, Castro, and Loscalzo 2011; Luger et al. 1997; Luger 2001) (Figure
1.2). Histone H1 acts as a linker histone that associates linker DNA located between the
nucleosomes (Thomas 1999). The N-terminal tail of histone proteins protrude from the nucleosome,
which is highly modified by various post-translational modifications (PTMs) that regulate chromatin
structure (Strahl and Allis 2000). The most common PTMs studied in histone proteins include lysine
acetylation and methylation, and serine/threonine phosphorylation (Kouzarides 2007). These
marks alter electrostatic interactions between histone-DNA and histone-histone contacts. For
instance, histone acetylation loosens histone-DNA interactions by neutralizing the positively
charged lysine residues, thus providing a more open chromatin environment. Histone PTMs are
regulated by chromatin modifying enzymes that add or remove the chemical groups (Marmorstein
and Zhou 2014). Writer proteins, such as acetyltransferases, methyltransferases, and kinases,
deposit the histone mark. The enzymes that remove the marks include deacetylases,
demethylases, and phosphatases (Bannister and Kouzarides 2011). Moreover, reader proteins can
also recognize specific histone modifications: bromodomains bind to acetyllysine residues, while
chromodomains recognize methyllysines.
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Figure 1.2 Nucleosomes form the basic repeating unit of chromatin, which consists of the
histone octameric core and DNA.
Figure adapted from (Weaver et al. 2017).
1.2 Mass spectrometry-based approaches to interrogate chromatin biology
Advancements in mass spectrometry-based proteomics have accelerated the discovery of
histone PTMs. To date, over 20 different PTMs have been identified on histone proteins, including
certain understudied and novel marks such as butyrylation and formylation that have been detected
but their function has not been studied extensively (Zhao and Garcia 2015). Liquid chromatography
coupled online with tandem mass spectrometry (LC-MS/MS) provides an unbiased and
comprehensive analysis of histone PTMs over a wide variety of model systems. The robustness in
identification and quantification of histone PTMs has become possible due to high mass accuracy
(<5 ppm), high resolution (>60,000), and high sensitivity (<amol) of MS instruments (Sidoli, Kori, et
al. 2019).
There are three MS-based methods that can be used for histone PTM analysis: bottomup, middle-down, and top-down (Figure 1.3) (Sidoli and Garcia 2017a; Lu et al. 2020; Moradian et
3

al. 2014). Top-down MS allows for PTM identification on intact histone proteins, as no proteolytic
digestion is performed prior to LC-MS analysis. This method is valuable in studying combinatorial
histone PTMs co-occurring in the same tail, as PTMs are often found in combination. However, this
method is computationally challenging, as there are only few computational programs that have
been developed for top-down analysis due to the large number of proteoforms that can coelute and
cofragment, which decreases sensitivity and makes PTM localization highly challenging (Yuan,
Arnaudo, and Garcia 2014; Lu et al. 2020). As a result, middle-down proteomics has been
developed to analyze combinatorial histone PTMs by generating long polypeptide chains (~50
amino acids) through enzymatic digestion by Glu-C (Sidoli, Lin, Karch, et al. 2015; Sidoli and Garcia
2017b). This approach, similar to top-down proteomics, provides information on co-existing PTMs
on the histone N-terminal tail. Our recent work outlined a detailed protocol in using middle-down
proteomics for identifying histone PTMs, where we focused on tips and benchmarks to evaluate
adequacy of performance of this workflow (Coradin et al. 2020). Still, both top-down and middledown methods require weak cation exchange-hydrophilic interaction chromatography (WCXHILIC), which is not typically used for general proteomics experiments.
Bottom-up MS is the most widely used method in quantifying relative abundance of histone
PTMs (Sidoli et al. 2016). Histones are derivatized using propionic anhydride to increase
hydrophobicity for reversed-phase chromatography and to block unmodified and monomethyl
lysine residues, allowing trypsin to cleave only at the C-terminal of arginine residues (PlazasMayorca et al. 2009). Trypsin digestion produces short polypeptides in the range of 600 - 2,000
Da, which are commonly easily ionized and identified with higher mass accuracy and resolution.
More importantly, MS/MS fragmentation is also enhanced, since shorter peptides are usually wellsuited for higher energy collisional dissociation (HCD) fragmentation. This strategy allows for
quantification of histone PTMs that are relatively close in amino acid sequence (i.e. H3K9/K14,
H3K18/K23).
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Figure 1.3 MS-based approaches to interrogate chromatin biology.
Figure adapted from (Switzar, Giera, and Niessen 2013)
1.3 Intersection between metabolism and epigenetics
Metabolism and gene expression are linked through the presence of metabolic enzymes
and metabolites that shuttle in the nucleus (Figure 1.4) (Boukouris, Zervopoulos, and Michelakis
2016; van der Knaap and Verrijzer 2016). Key metabolites such as acetyl-CoA and S-adenosyl
methionine enter the nucleus and become cofactors for chromatin modifying enzymes that
modulate gene expression through posttranslational modifications on histone tails. Aside from
metabolites, certain metabolic enzymes are also translocated in the nucleus. Subunits of the
pyruvate dehydrogenase complex have been shown to translocate from the mitochondria to the
nucleus during S phase and produce acetyl-CoA from pyruvate for histone acetylation (Sutendra
et al. 2014). Also, ATP citrate lyase (ACLY) localizes to the nucleus and converts citrate to acetylCoA for histone acetylation and adipocyte GLUT4 expression (Wellen et al. 2009).

5

Figure 1.4 Metabolism and epigenetics are linked by enzymes and metabolites that shuttle
into the nucleus.
Figure adapted from (Boukouris, Zervopoulos, and Michelakis 2016)
1.3.1 ACSS2 and histone acetylation
Acetyl-CoA synthetase 2 (ACSS2) is another great example of a metabolic enzyme that
has dual roles in the cytoplasm and nucleus (Pietrocola et al. 2015). Its major role in the cytoplasm
is to produce acetyl-CoA from acetate for lipid synthesis, while its nuclear role involves production
of acetyl-CoA for histone acetylation. It has been shown in glioblastoma cells that during glucose
deprivation, ACSS2 is phosphorylated at S659 by AMP-activated protein kinase (AMPK), resulting
in ACSS2 nuclear translocation and activation of autophagy genes by its interaction with
transcription factor EB (TFEB) (Li et al. 2017). Additionally, recent work has demonstrated via
chromatin immunoprecipitation followed by sequencing (ChIP-seq) analysis in mouse Cath.-adifferentiated (CAD) cells that ACSS2 is chromatin-bound together with the histone
6

acetyltransferase CBP and is associated with enrichment of histone acetylation, specifically at
H4K5, H4K12, and H3K9 (Mews et al. 2017). In Saccharomyces cerevisiae, the yeast acetyl-CoA
synthetase ACS2 is the predominant nuclear acetyl-CoA producing enzyme, and it localizes to the
nucleus for histone acetylation and global gene activation (Takahashi et al. 2006). Moreover,
histone acetylation is very dynamic in yeast, specifically during glucose-induced cell cycle reentry
from quiescence (Mews et al. 2014). Histone acetylation responds rapidly to changes in metabolic
state, wherein there is decreased acetylation during quiescence and increases, specifically at
growth genes, once cells exit quiescence. The crucial role of nuclear ACSS2 is further
demonstrated in studies showing that knockdown of ACSS2 in the hippocampus of mice impairs
the formation of long-term memories and reduces the expression of immediate-early genes (Mews
et al. 2017). Overall, these findings support the model that nuclear localization of ACSS2 is
associated with histone acetylation at specific regions and gene activation.
1.3.2 Exogenous and endogenous sources of acetate
As acetyl-CoA is an essential metabolite and cofactor for various biological processes, the
availability of its precursor acetate is crucial in regulating acetyl-CoA levels (Figure 1.5). In humans,
the main source of exogenous acetate is from saccharolytic fermentation of intestinal bacteria,
where indigestible carbohydrates are broken down by the enteric bacteria to generate acetate,
propionate, and butyrate at 3:1:1 ratio (Bose, Ramesh, and Locasale 2019; Louis, Hold, and Flint
2014; Schug, Vande Voorde, and Gottlieb 2016). Alcohol consumption and ethanol metabolism in
the liver is also a considerable source for acetate. In the liver, alcohol dehydrogenase (ADH)
catalyzes the formation of acetaldehyde from ethanol, using NAD+ as a cofactor (Bose, Ramesh,
and Locasale 2019; Lieber 1997). Acetaldehyde is highly toxic, thus it is rapidly converted to
acetate by aldehyde dehydrogenase (ALDH). Interestingly, alcohol has also been shown to provide
a source of acetate for histone acetylation in neurons (Mews et al. 2019). In vivo stable isotope
labeling experiments have demonstrated that alcohol-derived acetate is utilized for rapid histone
acetylation via ACSS2 activity, and alcohol-induced learning is dependent on ACSS2. Lastly,
7

another source of exogenous acetate is through acetylcholine hydrolysis by acetylcholinesterase
(AChe) at synapses, where AChe degrades acetylcholine to acetate and choline (Soreq and
Seidman 2001).

Figure 1.5 Exogenous and endogenous sources of acetate.
Figure adapted from (Bose, Ramesh, and Locasale 2019).
Since acetyl-CoA is a key intermediate molecule for metabolism and epigenetics, the ability
to generate acetate from endogenous sources is crucial in maintaining cellular processes,
especially when cells undergo metabolic stress such as nutrient deprivation. In cells, acetate is
produced by protein deacetylases and acetyl-CoA thioesterases (Hosios and Vander Heiden
2014). Acetyl-CoA thioesterases (ACOTs) hydrolyze acyl-CoAs in peroxisomes and produce
acetate that is exported to the cytosol or mitochondria (Hunt, Siponen, and Alexson 2012). Acetate
is also generated endogenously though deacetylation from proteins such as histones, which are
8

some of the most abundant proteins in the cell. Histone deacetylases (HDACs) use either zinc or
NAD+-dependent mechanisms to remove acetyl groups from histone proteins, producing a pool of
acetate that can be utilized in the nucleus (Seto and Yoshida 2014). This nuclear acetate pool can
be used by ACSS2 to produce acetyl-CoA for histone acetylation and transcriptional activation, as
demonstrated by several studies (Bulusu et al. 2017; Mews et al. 2017; Li et al. 2017; Comerford
et al. 2014). In post-mitotic neurons, nuclear ACSS2 produces acetyl-CoA locally for histone
acetylation and upregulation of immediate-early genes (Mews et al. 2017). During glucose
deprivation in glioblastoma cells, histones are acetylated using acetate generated by histone
deacetylases, demonstrating the role of ACSS2 in maintaining local acetyl-CoA pools (Li et al.
2017).
1.4 Role of nuclear ACSS2 in acetate recycling from histones
Several recent studies have proposed the crucial role of nuclear ACSS2 in maintaining
histone acetylation, especially during metabolic alterations, by utilizing acetate released from
histone deacetylase reactions. In hypoxic tumors, ACSS2 is known to be predominantly expressed
in the nucleus, where it utilizes acetate released by HDACs to generate acetyl-CoA to maintain
histone acetylation and prevent apoptosis and facilitate tumor growth (Bulusu et al. 2017). A similar
result was also observed in glioblastoma cells that are incubated in the absence of glucose, wherein
pre-treating the cells with HDAC inhibitors reduced acetyl-CoA levels and reduced histone
acetylation at the promoters of lysosomal genes (Figure 1.6) (Li et al. 2017; Li, Qian, and Lu 2017).
Overall these studies hypothesize a model wherein there is an increased ACSS2 localization in the
nucleus upon metabolic changes such as glucose or oxygen deprivation, then ACSS2 maintains
histone acetylation by recapturing acetate released by HDAC reactions. The acetyl-CoA produced
is then utilized by HATs to acetylate histones and mediate rapid transcriptional activation of genes
critical for cell growth and survival. These studies indicate a local transfer of acetate mediated by
ACSS2, HATs, and HDACs; however, a direct transfer of acetate between histone residues
remains to be demonstrated, which is one of the focus of this work.
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Figure 1.6 Proposed mechanism of nuclear ACSS2 in maintaining histone acetylation.
Figure adapted from (Li, Qian, and Lu 2017)
An additional fundamental question is how ACSS2 is being recruited to chromatin or to
specific regions in the genome to facilitate acetate recycling by providing a local acetyl-CoA pool
for histone acetylation and gene activation. Even though ACSS2 lacks known histone- and DNAbinding domains, it still binds chromatin at sites that overlap with histone acetylation sites (Mews
et al. 2017). Thus, I predict that ACSS2 associates with chromatin indirectly through interaction
with

other

transcription

factors

or

histone

binding

proteins.

In

glioblastoma

cells,

immunoprecipitation-MS analysis showed that ACSS2 associates with TFEB, which is a
transcription factor that upregulates expression of lysosomal genes (Li et al. 2017; Sardiello et al.
2009). In vitro pulldown assays showed that ACSS2 and TFEB bind directly to each other, and the
specific interaction domains were mapped out. In CAD cells, our lab demonstrated that ACSS2
interacts with CBP, a prominent histone acetyltransferase (Mews et al. 2017). It remains unclear
whether this interaction is direct. However, with the emerging studies highlighting the role of nuclear
ACSS2 and histone acetylation, it is possible that it forms a complex containing CBP, which will
utilize the acetyl-CoA generated by ACSS2 to acetylate histones.
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In the following chapters I will discuss two studies by which we interrogated nuclear ACSS2
and its recruitment to chromatin to mediate a local transfer of acetate. In the second chapter, we
utilized proteomic and genomic approaches to determine whether intact acetate can be transferred
between histone lysine residues in vitro and in vivo using yeast quiescence exit as a change-ofstate model. Using stable isotope labeling, we demonstrated that intact acetate can be directly
transferred between histone sites both in vitro and in vivo. By performing chromatin
immunoprecipitation followed by next generation sequencing (ChIP-seq), we observed ACSS2
recruitment to chromatin, which is consistent with previous studies, and growth genes that were
induced during quiescence exit were preferentially targeted by ACSS2. Our study reveals a direct
transfer of intact acetate that is mediated by ACSS2, a mechanism that may be critical during
alterations in metabolic states. More importantly, our study also highlights the importance of
histones as “reservoirs” for acetyl groups, which can be rapidly mobilized when transcriptional
demand increases.
In the third chapter, we utilize mass spectrometry to identify proteins that aid in recruiting
ACSS2 to chromatin in maintaining local histone acetylation. We utilized Cath.-a-differentiated cells
(CAD) cells and mice that are either WT or KO for ACSS2, and by using immunoprecipitation
coupled to mass spectrometry (IP-MS), we found the nucleus accumbens associated 1 (NACC1)
protein as a candidate ACSS2 interactor. We profiled protein levels of nuclear NACC1 and ACSS2
during differentiation and found that ACSS2 increases steadily during differentiation, while NACC1
increases only during the intermediate time points. By performing ChIP-seq, we found high overlap
between NACC1 and ACSS2 peaks in differentiated CAD cells. Gene ontology analysis of ACSS2
and NACC1 peaks show enrichment near genes of cell-cell adherens, cytoplasmic, and membrane,
which are genes important in CAD differentiation and formation of neuronal processes. Overall, our
results suggest that in the context of neuronal development, ACSS2 interacts with NACC1 at
chromatin to maintain local histone acetylation and regulate expression of genes necessary for
differentiation, consistent with the important role of nuclear ACSS2 during metabolic alterations.
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In the fourth chapter of this dissertation, we focus on optimizing the current histone middledown workflow, and we present a detailed protocol in performing middle-down MS of hypermodified
histone tails. We improved sample retention during the desalting step with the use of porous
graphitic carbon (PGC). We also tested different salts in the WCX-HILIC buffers for their effect on
retention, selectivity, and reproducibility, and we found that replacing the ammonium ion with
ethylenediammonium ion had improved effects on selectivity and retention. Lastly, we provided
some guidelines on how to evaluate adequacy of performance of this workflow. Our findings provide
significant improvements in the current middle-down workflow and a more streamlined way to
evaluate performance.
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CHAPTER 2 : Enzymatic transfer of acetate on histones from lysine reservoir sites to
lysine activating sites

This chapter is based on work that has been published, and figures are reproduced from this
published manuscript in accordance with applicable copyright and editorial policies. This chapter is
based on the paper:
Mendoza, M., G. Egervari, S. Sidoli, G. Donahue, D. C. Alexander, P. Sen, B. A. Garcia,
and S. L. Berger. 2022. 'Enzymatic transfer of acetate on histones from lysine reservoir
sites to lysine activating sites', Sci Adv, 8: eabj5688.

2.1 Introduction
While long thought to be relegated to separate cellular compartments, recent findings
highlight connections between metabolism and gene expression through the presence of metabolic
enzymes and metabolites that shuttle between the cytoplasm and the nucleus (Egervari, Glastad,
and Berger 2020; Li et al. 2018; Boukouris, Zervopoulos, and Michelakis 2016; van der Knaap and
Verrijzer 2016; Etchegaray and Mostoslavsky 2016). Key metabolites modulate gene expression
through posttranslational modifications of histone tails. For example, S-adenosyl methionine and
acetyl-CoA contribute methyl- and acetyl-groups for deposition on histone proteins through
methyltransferase and acetyltransferase enzymes, respectively (Figlia, Willnow, and Teleman
2020; Bannister and Kouzarides 2011). Nuclear acetyl-CoA pools are affected by dynamic activities
of histone acetyltransferases (HATs) and histone deacetylases (HDACs) (Figlia, Willnow, and
Teleman 2020), as well as by increased nuclear localization of various metabolic enzymes that
contribute to acetyl-CoA production (Sivanand, Viney, and Wellen 2018; Boukouris, Zervopoulos,
and Michelakis 2016). Acetyl-CoA synthetase 2 (ACSS2), for example, translocates to the nucleus
and converts acetate into acetyl-CoA that can be utilized for histone acetylation and can lead to
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rapid gene activation, which is vital when cells are under metabolic stress (Boukouris, Zervopoulos,
and Michelakis 2016; van der Knaap and Verrijzer 2016; Mews et al. 2019).
Metabolites retained in chromatin not only function as protein modifications for gene
regulation but also have been proposed to act as storage for utilization during low nutrient
availability. Histones are the most abundant class of proteins in the nucleus, and thus have the
capacity to store substantial amounts of metabolites. In human cells, recent estimates suggest that
~3µM acetate could be produced from deacetylation of ~0.1% of histone lysine residues for
generation of acetyl-CoA (Ye and Tu 2018). This highlights the substantial amount of acetate that
has the potential to be released from histones, which can then be directly converted to acetyl-CoA
via nuclear ACSS2. Indeed, recent studies have proposed that acetate released from histones can
be recycled to maintain histone acetylation, especially during metabolic stress such as glucose or
oxygen deprivation (Bulusu et al. 2017; Mews et al. 2017; Li, Qian, and Lu 2017; Li et al. 2017).
ACSS2 has been proposed to recapture acetate released by HDACs, and to provide a local pool
of acetyl-CoA for histone acetylation (Li et al. 2017; Bulusu et al. 2017). Overall, these findings
suggest that there may be recycling of acetate from stored histone acetylation to new sites of geneactivating histone acetylation sites, and further suggest that this recycling requires direct
collaboration of histone deacetylases, ACSS2, and histone acetyltransferases. While this model
potentially accounts for dynamic and rapid changes in histone acetylation for gene activation, direct
transfer of intact acetate between histone lysine residues remains to be demonstrated.
Here, we utilize proteomic and genomic approaches to query whether intact acetate can
be directly transferred between histone residues in vitro, and whether local transfer of intact acetyl
groups can be detected in vivo using a change-of-state model in yeast. We interrogate whether
ACSS2 can facilitate the local transfer of acetyl groups. Our results point to direct transfer of intact
acetate that is mediated by ACSS2, underscoring a critical function of acetate transfer in utilizing
local and nuclear acetate pools for histone acetylation and rapid transcriptional activation.
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2.2 Results
2.2.1 In vitro assays demonstrate direct transfer of intact acetate between histone acetyllysine residues
We tested whether histone acetyl transfer can occur in vitro in a reconstituted system with
purified enzymes. We used a synthetic histone peptide as substrate, spanning the first 42 amino
acids of the histone H3.1 tail, wherein an acetylation site— K23 acetylation (H3K23ac) as the most
central site within the peptide—was labeled via “heavy” acetylation with deuterium (Figure 2.1A).
This leads to a molecular weight increase of 3 Da for the fully deuterated acetyl group, which allows
tracking the fate of the intact acetyl group enzymatically released from the labeled acetylation site.
We incubated the synthetic peptide in the presence of an HDAC and ACSS2. Cofactors, ATP and
coenzyme A were included to resemble an environment of high local concentration of these
components, which are necessary for the ACSS2 reaction. For full acetyl-CoA production from
enzyme action, we expected the following: (1) removal of labeled intact acetyl group (ac*) by an
HDAC to produce fully labeled acetate; and (2) conversion of the labeled intact acetate by ACSS2
to generate labeled acetyl-CoA (Figure 2.1B).
We first carried out several control reactions. For deacetylation (see step 1, schematic
Figure 2.1B), we utilized HDAC1 because it is an abundant enzyme in the nucleus involved in
transcription (Haberland, Montgomery, and Olson 2009; Seto and Yoshida 2014) and because it
readily deacetylates histones H3 and H4 (Johnson et al. 2002). Indeed, we found that HDAC1
efficiently deacetylated the synthetic histone peptide in vitro to produce fully labeled acetate (Figure
2.1C). To assess whether ACSS2 can produce acetyl-CoA from histone deacetylation, we utilized
a targeted mass spectrometry-based approach using Selected Reaction Monitoring (SRM) to
detect fragment ions specific to fully labeled acetyl-CoA (Sidoli, Trefely, et al. 2019). We first
confirmed that ACSS2 can utilize labeled acetate to produce labeled acetyl-CoA in vitro (Figure
2.1D), thus demonstrating step 2 from schematic Figure 2.1B.
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We next put steps 1 + 2 together (schematic Figure 2.1B), testing whether the synthetic
histone peptide can be utilized by ACSS2 as a source of acetate to generate acetyl-CoA. We
incubated the H3K23ac* peptide with HDAC1 and ACSS2 (2 hr) and detected fully labeled acetylCoA generated from the acetate released from deacetylation of the histone peptide (p<0.0001, twoway ANOVA) (Figure 2.1E). Additionally, we demonstrated that both enzymes (and cofactors) were
necessary for this production of acetyl-CoA via individual enzyme (and co-factor) drop-out (Figure
2.1F). Overall, these results show that an acetylated histone peptide acts as a source for acetylCoA production via sequential action of HDAC1 and ACSS2, via transfer of intact acetate.
We further dissected the role of ACSS2 in dynamic local histone acetylation, testing
whether the fully labeled acetyl-CoA produced by ACSS2 can be re-incorporated into the histone
peptide (step 3, schematic Figure 2.1B). As HAT, we used CBP based on its role in gene activation
and its association with ACSS2 in vivo (Mews et al. 2017). We applied two different methods to
identify and quantify acetylation. First, we utilized Parallel Reaction Monitoring (PRM) to specifically
target the synthetic peptide and its various acetylated forms (Sweredoski, Moradian, and Hess
2017). This method attained sufficient fragmentation of the synthetic peptide, which was crucial in
identifying different acetylation sites on the peptide (Supplementary Figure 2.1A).
We then performed in vitro reactions with the H3K23ac* peptide and, when all three
enzymes (HDAC1, ACSS2, and CBP) were present, we identified the presence of a one newly
labeled peptide—H3K18ac*—that was fully deuterated and thus resulting from complete transfer
of intact acetate (Supplementary Figures 2.1B and 2.1C). To verify the identity of the newly labeled
peptide, we used a second method to quantify H3K18ac*, by digesting the synthetic peptide after
the reaction followed by analysis using Data Independent Acquisition (DIA), which is a method
routinely used in quantifying histone PTMs from cells and tissues (Supplementary Figure 2.2A)
(Karch, Sidoli, and Garcia 2016; Sidoli et al. 2016; Sidoli, Lin, Xiong, et al. 2015; Sidoli, Simithy, et
al. 2015). ACSS2 was crucial in mediating the transfer, as there was a significant decrease in
H3K18ac* when ACSS2 was not present (p<0.001, one-way ANOVA) (Figure 2.1G and
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Supplementary Figures 2.2B and 2.2C). Further, HDAC1 and CBP were also critical in the transfer
(Figure 2.1G and Supplementary Figure 2.2C).
These results show that in a purely in vitro system with HDAC1, ACSS2 and CBP HAT,
intact acetyl groups are transferred from one histone lysine residue to another. While the reason
and mechanism for transfer uniquely to H3K18ac is not clear, the detection of acetyl transfer in
vitro supports the hypothesis that ACSS2, collaborating with HDAC and HAT enzymes, can
facilitate local transfer of acetyl groups between histone sites.
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Figure 2.1 ACSS2 mediates local transfer of acetyl groups between histone lysine residues.
(A) Synthetic peptides spanning the first 42 amino acids of the histone H3 tail were designed for
the in vitro assays. The acetyl group on K23 is deuterated (K23ac*) to track the transfer. The last
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amino acid in the peptide was heavy labeled (13C, 15N) to discriminate the synthetic peptide from
peptides derived from endogenous histones. (B) Schematic for the in vitro assays performed for
acetyl-CoA analysis. The numbers illustrate the three consecutive reactions that must occur for
acetyl-transfer to take place. (C) Deacetylation reaction with HDAC1 and synthetic histone peptide.
P value (P = 0.0136) was calculated using unpaired t-test. (D) ACSS2 can generate deuterated
acetyl-CoA (D3-acetyl-CoA) from deuterated acetate (D3-acetate), showing step #2 from the
schematic in Fig. 2B can take place. Bar graphs represent mean ± SD, n=3/group. (E) ACSS2 can
generate D3-acetyl-CoA from K23ac* as the source for acetate. Bar graphs represent mean ± SD,
n=3/group. P values were calculated using two-way ANOVA with Sidak’s multiple comparisons test.
**** padj < 0.0001.(F) D3-acetyl-CoA is produced from deacetylation of histone peptides, showing
steps #1 and #2 from the schematic in b can take place. Complete rxn indicates all three enzymes
(HDAC1, ACSS2, and CBP) are present. Bar graphs represent mean and SD, n=3/group. (G)
H3K18ac** is observed when all three necessary enzymes were added in the in vitro reactions. Bar
graphs represent mean and SD, n=3/group. p-values were calculated using one-way ANOVA with
Dunnett’s multiple comparisons test. *** padj < 0.001.
2.2.2 Acetyl-groups are transferred between histone residues during yeast quiescence exit
To investigate acetyl-group transfer in vivo, we used a well-characterized change-of-state
model in S. cerevisiae, in which cells exit quiescence and enter exponential growth (Friis et al.
2009). Importantly, quiescence exit is accompanied by exceedingly rapid transcriptional changes
resulting in increased expression of growth genes (~500 genes) and decreased expression of
stress genes (~100 genes) (Friis et al. 2009; Mews et al. 2014). We and others have shown that
exit from quiescence is characterized by dynamic changes of histone acetylation (Friis et al. 2009;
Mews et al. 2014) (but not of histone methylation): acetylation is low during quiescence and
increases during quiescence exit specifically at growth genes (Mews et al. 2014). Based on our in
vitro results, we hypothesized that direct transfer of acetyl groups between histone lysine residues
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could contribute to the remarkably rapid and dynamic histone acetylation changes during
quiescence exit to support transcriptional activation.
To test this, yeast cultures were induced to enter quiescence by replacing glucose-rich
media with distilled water for 7 days (Friis et al. 2009; Mews et al. 2014). To trace acetyl groups,
water was supplemented with heavy labeled d3-acetate (Figure 2.2A). Subsequently, cells were
washed to remove residual heavy acetate, and quiescence exit and proliferation were induced by
re-supplying glucose and other nutrients. To ensure that the washing step was sufficient to
eliminate extracellular d3-acetate that had not been internalized, aliquots of the media were
sampled before and after washing and d3-acetate levels were measured by mass spectrometry.
We observed a significant decrease in d3-acetate (p<0.0001, unpaired T-test) after the wash,
indicating that the washing step was efficient in removing excess extracellular d3-acetate
(Supplementary Figure 2.3A). Heavy labeling of histone acetylation was then measured using
peptide-centric mass spectrometry (Sidoli, Lin, Xiong, et al. 2015; Sidoli, Simithy, et al. 2015). We
carried out three biological replicate experiments. We note that labeling was variable in these
experiments, specifically at the lower abundance histone acetylation sites H3K9 and H3K27. This
was due to the difficulty of the data analysis when analyzing labeling rates of lowly abundant
modifications. Also, several histone peptides are isobaric (i.e. H3K9ac/K14ac), so quantification of
the heavy labeling occurs at the fragment ion level, which are at lower intensity than the intact mass
of the peptides. As a result, extracting the signal of the fragment ions containing the heavy labeling
remains challenging, which resulted in variability of labeling rates.
Nevertheless, we observed an intriguing pattern of deuterated acetate incorporation on
histone H3 in this model. Heavy labeling at K14ac, K18ac and K23ac was more enriched in
quiescent cells compared to labeling of K9ac and K27ac (p<0.001, two-way ANOVA) (Figure 2.2B).
These results indicate that fully labeled acetate was preferentially stored on specific histone H3
lysine residues in quiescent yeast cells. Strikingly, during quiescence exit, heavy label incorporation
increased at K9ac and K27ac, while the heavy labeling of K14ac, K18ac and K23ac decreased
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(Figure 2.2B). These distinct labeling patterns (and, importantly, the fact that d3-acetate was
washed out from quiescent cultures before re-feeding with glucose) suggest that heavy labels
deposited on specific lysine residues during quiescence were transferred onto other lysines during
quiescence exit.
For histone H4, we were able to accurately quantify only H4K16ac*, as acetylation at other
lysine residues (K5/8/12) is not distinguishable—these sites have the same precursor m/z ratio and
they also co-elute by reverse-phase chromatography (Yuan et al. 2018; Yuan et al. 2015). The
highest enrichment of heavy labeling at H4K16ac occurred during quiescence and heavy label was
decreased during quiescence exit (Figure 2.2C). These data suggest that, similarly to H3K14ac,
K18ac and K23ac, H4K16ac might be an important site of acetate storage in quiescent yeast cells,
from which acetyl groups can be transferred onto other residues as transcriptional demand
increases.
Overall, our results suggest a direct transfer of intact acetate between histone residues
during yeast quiescence exit. To further demonstrate that d3-acetate is derived from histone
acetylation during quiescence exit, we utilized a targeted mass spectrometry approach to detect
and quantify d3-acetate in yeast cells. We induced proliferation by adding glucose-rich media in
the presence of HDAC inhibitors Trichostatin A and nicotinamide, predicting that the inhibitors
would prevent release of d3-acetate from histones during quiescence exit. Indeed, we detected a
spike of intracellular d3-acetate during the early exit time points, which was not detected in the
HDACi-treated cells (Supplementary Figure 2.3B). This suggests that histone acetylation is the
major source of d3-acetate in cells exiting quiescence, further supporting our model of acetyl-group
transfer between histone lysine residues.
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Figure 2.2 Acetyl groups are transferred between histone lysine residues during yeast
quiescent exit.
(A) Experimental design for d3-acetate labeling during yeast quiescence. (B) Heavy acetylation
detected on histone H3 residues. Specific histone residues (K14, 18, 23) have higher incorporation
of heavy acetate during quiescence, while K9 and K27 have higher incorporation of heavy acetate
during quiescent exit, at both early and late time points. P values were calculated using two-way
ANOVA with Sidak’s multiple comparisons test. * padj < 0.05, ** padj < 0.01, *** padj < 0.001, ****
padj < 0.0001. (C) Heavy acetylation detected for H4K16 site, showing more enriched incorporation
of heavy acetate during quiescence. P value was calculated using unpaired t-test * P = 0.0282.
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2.2.3 Chromatin-bound Acs2 is linked to transcriptional changes during quiescence exit
The yeast mass spectrometry data indicated that acetyl groups can be transferred between
lysine residues during quiescence exit. We next investigated whether ACSS2 is at a genomic
location to facilitate this transfer. Similar to ACSS2 in mammalian cells (Mews et al. 2017; Li et al.
2017), the yeast orthologue Acs2 translocates from the cytoplasm to the nucleus – indeed, in freely
proliferating yeast, over 95% of Acs2 shows nuclear localization (Takahashi et al. 2006).
Intriguingly, while mammalian ACSS2 is chromatin-bound in neurons (Mews et al. 2017) and other
cell types (Li et al. 2017), it remains unknown whether yeast Acs2 binds to chromatin.
To investigate whether Acs2 is recruited to chromatin in yeast, we performed chromatin
immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) using a previously
validated mammalian ACSS2 antibody (Mews et al. 2017) that cross-binds to yeast Acs2
(Supplementary Figure 2.4A) and in parallel, an S. cerevisiae strain expressing endogenously TAPtagged Acs2 (YLR153C; Supplementary Figure 2.4B). Using both approaches, Acs2 was
chromatin-bound and importantly displayed similar patterns of enrichment during quiescence (Q),
quiescence exit (early, 30 min or late, 240 min) and log proliferation (Figures 2.3A and 2.3B).
Specifically, Acs2 peaks detected with the ACSS2 antibody (n=1,438) were induced during
quiescence exit with highest enrichment in log proliferating cells (Figure 2.3A, left). Importantly, at
the same genomic loci, TAP-tagged Acs2 showed strong enrichment in a similar pattern (Figure
2.3A, right). Similarly, TAP-Acs2 peaks (n=1,284) were recruited throughout quiescence exit into
log proliferation and showed a strong overlap with non-tagged Acs2 enrichment at the same
genomic loci (Figure 2.3B). Chromatin recruitment and overlapping patterns of Acs2 and TAP-Acs2
enrichment were also observed during quiescence and early quiescence exit, although the number
of peaks was markedly lower in these states (148 Acs2 peaks in quiescence, 119 Acs2 peaks in
E30 and 763 Acs2 peaks in E240) (Supplementary Figures 2.5A-C). Gene ontology analysis of
Acs2 peaks in log proliferating cells revealed significant enrichment near genes of cytoplasmic
translation (n=109 genes, p=3.9e-50), translation (n=138 genes, p=1.27e-37) and ribosome
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components (n=128 genes, p=2.06e-35) (Figure 2.3C). We observed similar GO categories in
quiescent and quiescence-exiting cells (Supplementary Figures 2.6A-C), suggesting that
chromatin-bound Acs2 is particularly important for regulating the expression of genes related to cell
growth and proliferation. Further, Acs2 peaks in log proliferating cells (Figure 2.3D, n=100
overlapping peaks, p=8.9e-4 from hypergeometric test) as well as in quiescent and quiescenceexiting cells (Supplementary Figures 2.7A-C) overlapped significantly with annotated growth genes
from the literature (Table 2.1).
We next investigated the relationship between Acs2 recruitment and gene expression.
Strikingly, growth genes induced through each consecutive stage of quiescence exit (n=52) were
significantly more likely to be targeted by Acs2 than an equal number of background genes with no
transcriptional changes (p<0.001, Monte Carlo simulation, Figure 2.3E). Similarly, a larger
proportion of growth genes with increased expression in log proliferating versus quiescent cells
(n=392 out of the 439 annotated growth genes) were targeted by Acs2 compared to background
genes (p<0.001, Monte Carlo simulation, Supplementary Figure 2.8). Overall, Acs2 preferentially
targeted genes with the largest transcriptional changes during quiescence exit, especially at E240
and LOG (Figure 2.3F). Taken together, these results link chromatin-bound Acs2 to transcriptional
regulation during yeast quiescence exit, particularly for genes related to growth and cell
proliferation.
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Figure 2.3 Chromatin-bound Acs2 regulates gene expression in S. cerevisiae.
(A,B) Acs2 is increasingly recruited to chromatin during cell proliferation. Endogenous untagged
and TAP-tagged Acs2 peaks called in LOG proliferating S. cerevisiae show considerable overlap
throughout quiescence exit. (A) Heatmaps ranked by endogenous Acs2 peaks. (B) Heatmaps
ranked by TAP-tagged Acs2 peaks. (C) Gene ontology analysis of Acs2 LOG peaks. Top5 most
enriched categories and number of genes in each are shown. (D) Venn diagram showing significant
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overlap (n=100, P=8.9e-4, hypergeometric test) of Acs2 LOG peaks (n=1142) and annotated
growth genes (n=439). (E) Acs2 is preferentially recruited to growth genes that show increased
expression during quiescence exit (n=52) compared to background genes. Gradient bars represent
gene expression changes and bar graphs show the percentage of genes targeted by Acs2
throughout the time course at growth genes and an equal number of randomly selected background
genes. (F) Acs2 is preferentially recruited to the most upregulated genes. Gradient bar ranked by
gene expression changes during quiescence exit. Genes with the largest expression changes
(LOG/Q) are on the right side (red), while the genes with smallest expression changes are on the
left side (green). Acs2 peaks called in specific states (Q, E30, E240 and LOG) are shown below in
cyan bars. These experiments were performed with the help of Gabor Egervari and Greg Donahue.
2.2.4 Histone marks show distinct acetylation patterns during yeast quiescent exit
Our in vivo heavy labeling results outlined distinct patterns of deuterated acetate
incorporation, and we observed transfer of intact acetate between lysine residues during
quiescence exit (Figure 2.2). To further investigate this relationship, we examined site-specific
changes in endogenous (light) acetylation during quiescence exit both globally and specifically at
genomic regions proximal to Acs2 binding. We profiled global histone acetylation levels via mass
spectrometry and ChIP-seq to investigate acetylation dynamics during the change of state. For all
lysine residues of histone H3, there was increasing mass spectrometry enrichment during
quiescence exit (Figure 2.4A), which is consistent with previous reports of increased histone
acetylation upon re-feeding with glucose (Mews et al. 2014; Friis et al. 2009). Intriguingly, however,
we observed marked differences in the behavior of specific lysine residues: acetylation of certain
sites (K9, K27) were negligible during quiescence and strongly induced upon exit, while acetylation
of others (K14, K18, K23) was more stable across different states (Figure 2.4A). Strikingly, these
distinct patterns overlapped with the distinct behavior of these marks in the in vivo transfer
experiment (Figure 2.2), which could indicate a previously unappreciated divergence in the
functional role of specific lysine residues. Indeed, lowly abundant histone acetylation marks tended
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to show more dynamic changes during quiescence exit (Figure 2.4) and acted as acceptors of
acetyl groups (Figure 2.2), suggesting a close relationship with transcriptional upregulation. On the
other hand, highly abundant acetyl marks tended to be less dynamic (Figure 2.4) and primarily
acted as donors of heavy-labeled acetyl groups during quiescence exit (Figure 2.2), indicating a
potential role as primary reservoirs of acetyl groups. We also observed induction of H4K16ac during
early and late exit (Figure 2.4B), and the fold change of K16ac enrichment was similar to those of
H3K14ac, K18ac, and K23ac.
To investigate acetylation dynamics using a parallel approach, we performed chromatin
immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) using antibodies specific
to the acetylated form of different lysine residues. Specifically, we examined the behavior of
H3K9ac, H3K18ac, H3K23ac and H3K27ac peaks during quiescence exit genome-wide. In line
with the mass spectrometry data, H3K18ac and H3K23ac peaks observed in quiescence
decreased during cell proliferation, while H3K9ac and H3K27ac log peaks were increased (Figure
2.4C, upper panels). In addition, H3K9ac and H3K27ac gains showed a strong overlap with Acs2
recruitment to chromatin (Figure 2.4C, lower panels), suggesting that local, chromatin-bound Acs2
might facilitate the deposition of acetyl groups at these residues.
To further assess the effect of Acs2 recruitment on local histone acetylation changes, we
examined H3K9ac, H3K18ac, H3K23ac and H3K27ac enrichment in the vicinity of Acs2 peaks
recruited during quiescence exit. Remarkably, during quiescence exit within 1kb of Acs2 peaks, the
enrichment of H3K18ac and H3K23ac decreased, while the enrichment of H3K9ac and H3K27ac
increased (p<0.0001, Permutation test) (Figure 2.4D). For example, Acs2 was recruited to the Shr3
gene during quiescence exit, a gene that encodes an integral endoplasmic reticulum protein, and
whose transcription was induced in proliferating cells with increased H3K9ac and decreased
H3K18ac (Supplementary Figure 2.9A), suggesting potential local acetyl group transfer. Similar
patterns of Acs2 recruitment, increased H3K9ac, decreased H3K18ac and increased gene
expression were observed at numerous other genes, including Yrb1, encoding a protein involved
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in nuclear RNA export (Supplementary Figure 2.9B), and Pre9, encoding a subunit of the 20S
proteasome (Supplementary Figure 2.9C).
Taken together, these results suggest that different histone lysine residues exhibit distinct
acetylation patterns during quiescence exit. Certain lysines appear to function as “reservoir” sites
that can act as nuclear stores of acetate during quiescence, while other sites mainly function as
“activating” sites that receive acetyl groups to mediate rapid transcriptional activation during
quiescence exit (Figure 2.4E). These acetylation changes are facilitated by locally bound Acs2 that
converts acetate into acetyl-CoA for re-incorporation.
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Figure 2.4 Dynamic changes in histone acetylation during yeast quiescence exit.
(A) Light acetylation detected for histone H3 residues. Global acetylation increases during
quiescence exit, but K9ac and K27ac induction is higher compared to H3K14/18/23. (B) Light
29

acetylation detected for H4K16ac, showing that acetylation increases during quiescence exit, at a
fold change similar to K14/18/23 residues. (C) Metaplots showing H3K18ac, H3K23ac, H3K9ac,
and H3K27ac 1kb away from Acs2 Q to LOG gained peaks, and its Acs2 recruitment in quiescent,
quiescence exiting and log proliferating cells. (D) Enrichment of H3K18ac Q peaks, H3K23ac Q
peaks, H3K9ac LOG peaks, and H3K27ac LOG peaks within 1kb of Acs2 gains during quiescence
exit. P values (p<0.0001) were calculated using Permutation test. (E) Proposed model on the
mechanism of ACSS2 in mediating local transfer of acetyl groups in chromatin from reservoir
acetylation sites to activating acetylation sites. These experiments were performed with the help of
Gabor Egervari and Greg Donahue.

2.3 Discussion
Our in vitro and in vivo findings show that intact acetate can be directly transferred between
histone acetyl-lysine residues. Using stable isotope labeling-based mass spectrometry, we
demonstrate in vitro that acetyl-CoA can be produced by ACSS2 from intact acetate released from
a histone peptide by HDAC1, and importantly, this acetyl-CoA can subsequently be utilized by CBP
to re-acetylate the histone peptide at a distinct site (Figure 2.1). Strikingly, three purified mammalian
enzymes (an HDAC, ACSS2 and a HAT) were sufficient to drive acetate transfer in vitro (Figure
2.1). Emphasizing the critical role of each of the three essential enzymes in facilitating the transfer,
we only detected significant transfer when all were present. Our in vitro work is, to our knowledge,
the first to empirically demonstrate that intact acetate released from histones via HDAC activity can
be directly converted to acetyl-CoA and utilized for histone acetylation. Previous studies have
proposed the possibility of acetate recycling in cancers where ACSS2 is highly expressed in the
nucleus. In glioblastoma cells, ACSS2 translocates to the nucleus during glucose deprivation (Li et
al. 2017) and produces acetyl-CoA that is incorporated into histone acetylation at promoters of
TFEB target genes, thereby increasing expression of lysosomal and autophagy genes. Intriguingly,
treatment with histone deacetylase inhibitor TSA led to a decrease in both nuclear acetyl-CoA
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levels and histone acetylation (using a pan-acetyl H3 antibody) at promoter regions of lysosomal
genes (Li, Qian, and Lu 2017; Li et al. 2017). In our model, these surprising observations are
potentially explained by decreased availability of acetate following HDAC inhibition, which impedes
acetyl-CoA production and histone acetylation.
ACSS2 has a well-established role in the cytoplasm, where it activates exogenous acetate
to produce acetyl-CoA for lipid biosynthesis (Luong et al. 2000). Several studies have identified
nuclear localization of ACSS2, both in mammalian (Comerford et al. 2014; Mews et al. 2017) and
yeast (Takahashi et al. 2006) model systems, and have highlighted ACSS2’s role in maintaining
nuclear acetyl-CoA pools for histone acetylation. In a recent study, mouse embryonic fibroblasts
(MEFs) that contain inactivating mutations in both ACSS2 alleles (ACSS2-/-) had substantial
decrease in 14C-acetate incorporation into lipids and histones (Comerford et al. 2014). Additionally,
these mice experienced reduced tumor growth, compared to ACSS2+/+ mice. The important role of
nuclear ACSS2 has been demonstrated in the context of learning and memory. Nuclear localization
of ACSS2 increases during neuronal differentiation in a cell line model and in primary mouse
hippocampal neurons, which is accompanied with ACSS2 chromatin recruitment, enrichment of
histone acetylation, and transcriptional activation of neuronal genes (Mews et al. 2017). Further,
reduction of ACSS2 in mouse dorsal hippocampus impaired long-term memory formation (Mews
et al. 2017). A common theme in these studies is metabolic alteration in the system, which
underscores an importance of ACSS2 as a key epigenetic regulator during metabolic stress. Here,
our findings indicate that during metabolic changes and especially in conditions with limited nutrient
availability in yeast, nuclear ACSS2 can utilize acetate stores from histones to produce acetyl-CoA,
which is then incorporated by HATs for histone acetylation and rapid transcriptional upregulation.
This outlines a novel mechanistic role for ACSS2 in the metabolic-epigenetic axis and invokes a
reservoir function of histones, an emerging concept proposed by recent reviews (Ye and Tu 2018;
Boon, Silveira, and Mostoslavsky 2020). Moreover, this hypothesis is similar to the notion of
metabolic channeling, wherein substrates or metabolites are directed between enzymes in close
31

proximity or as part of multiprotein complexes (Sweetlove and Fernie 2018). While contested by
some groups (Bakker et al. 2000; Dexter et al. 2018), others suggest that reaction rates could be
increased by bringing enzymes close to each other, rather than having them distributed throughout
the cell (Aguilar-Arnal et al. 2016). Based on our in vitro and in vivo findings, we postulate that
acetate could potentially be channeled by HDAC(s), ACSS2, and HAT(s) to mediate local histone
acetylation and rapid gene activation.
Acs2 in yeast has also been characterized as a nuclear metabolic enzyme important for
histone acetylation and gene activation. Studies using a temperature-sensitive Acs2 strain show
decrease in histone acetylation compared to the wild-type strain (Takahashi et al. 2006). While it
has been reported that Acs2 is nuclear in yeast, our findings further reveal that Acs2 is bound to
chromatin (Figure 2.3). By performing ChIP-seq using a commercially available ACSS2 antibody
(that cross-reacts to yeast Acs2) and an endogenously TAP-tagged Acs2 strain, we observed Acs2
recruitment to chromatin during quiescence, quiescence exit, and log proliferation (Figure 2.3).
More importantly, we found that induced growth genes during quiescence exit were preferentially
targeted by Acs2, suggesting that Acs2 is recruited at these regions to produce acetyl-CoA and
promote gene expression (Figure 2.3). In fact, Acs2 recruitment overlapped with increased
enrichment of H3K9ac and H3K27ac (Figure 2.4C). Also consistent with previous reports (Friis et
al. 2009), our mass spectrometry analysis showed increased global histone acetylation during
quiescence exit, particularly at H3K9 and H3K27. In addition, stable isotope labeling experiments
using d3-acetate indicated that these sites are highly enriched with heavy acetate labeling during
quiescence exit (Figure 2.2), suggesting that intact acetyl-groups were transferred from
neighboring sites that initially stored heavy acetate during quiescence. A previous study in yeast
demonstrated that acetylation at specific lysine residues such as H3K9 and H3K27 is highly
induced upon quiescence exit through Gcn5 acetyltransferase activity (Friis et al. 2009), which is
consistent with our findings.
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Our study indicates the importance of histones as reservoirs for acetyl groups, which can
be rapidly mobilized for histone acetylation and transcriptional activation. Strikingly, we observed
that there are different patterns of acetylation changes occurring during quiescence exit, wherein
some sites are more highly induced than others upon exit. Thus, we hypothesize that specific lysine
residues can function as “reservoir” acetylation sites to serve as local stores for acetyl groups
(Figure 2.4E). Then, acetate is released and transferred to activating acetylation sites when cells
exit quiescence and transcriptional demand increases. Although we propose histones as reservoirs
for acetyl groups, several nuclear non-histone proteins are also HDAC substrates. For instance,
HDAC1 interacts with and deacetylates the tumor suppressor protein p53, leading to p53
degradation (Luo et al. 2000). Several lysine acetyltransferases, such as p300, are also
dynamically acetylated and deacetylated (Black et al. 2008). However, considering their nuclear
stoichiometry, histones are likely the most important source with strongest influence on gene
regulation. Histone proteins are highly abundant in the nucleus, and thus can store substantial
amounts of acetate (Ye and Tu 2018). Moreover, our in vivo experiments show that HDACi
treatment prevents the release of d3-acetate during quiescence exit (Supplementary Figure 2.3B),
further corroborating the likely role of histones as acetyl-group reservoirs.
While we demonstrate this acetyl transfer in yeast quiescence exit as a change-of-state
model, future studies will address these mechanisms in mammalian change-of-state models such
as neuronal differentiation or in disease models such as cancer, wherein some tumors are more
preferentially dependent on acetate for growth (Comerford et al. 2014). It remains to be determined
whether a local transfer of acetyl groups occurs when these cells undergo metabolic stress, which
could then drive the expression of genes essential for survival. Additionally, further studies will be
necessary to interrogate the spatial constraints of local acetyl-CoA production by ACSS2. This
question is particularly important in light of recent studies highlighting the importance of phase
separated domains in chromatin for transcriptional activation (Zhang and Kutateladze 2019;
Narlikar 2020). Coactivator proteins such as MED1 and BRD4 have been found to associate in
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phase separated condensates to drive gene expression (Boija et al. 2018). It is possible that an
increased local acetyl-CoA pool is generated at these domains though ACSS2 activity, which is
important for maintaining histone acetylation and gene activation.
In summary, our findings reveal direct transfer of intact acetate between histone acetyllysine residues, by coordinated activity of epigenetic and metabolic enzymes. These novel
mechanisms may be critical to maintain proper epigenetic and transcriptional regulation during
changes in metabolic states of the cell.
2.4 Methods
2.4.1 Sample preparation for in vitro peptide reactions
Synthetic histone peptides corresponding to the first 42 amino acids of the histone H3.1
tail were purchased from New England Peptide. In vitro reactions were performed by incubating 20
µM synthetic peptide with 500 nM ACSS2, 1.5 µM HDAC1, 70 nM CBP, 20 µM ATP, and 100 µM
coenzyme A for 2 hr at 37˚C. The reaction buffer consists of 150 mM NaCl, 50 mM HEPES pH 7.5,
1 mM MgCl2. After incubation, samples were prepared for either acetyl-CoA or peptide analysis.
For acetyl-CoA analysis, the samples were quenched by adding acetonitrile + 0.6% formic
acid (FA) solution. The samples were vortexed, and 100% methanol was added in excess to
precipitate proteins in the sample. Then the samples were centrifuged for 3400 x g for 5 min at
room temperature, and the supernatant was transferred to a new tube, making sure the pipet tip
does not touch the pellet. The samples were dried in the speedvac. Once ready to inject in the MS,
the samples were reconstituted in Buffer A (10 mM ammonium bicarbonate pH 9.50).
For peptide analysis, the reactions were quenched by adding 0.1% trifluoroacetic acid
(TFA). The pH of all the samples were checked to make sure all samples were acidic (pH < 2).
Samples were desalted using C18 stage tips and eluted in 40% acetonitrile in 0.1% FA. The 40%
acetonitrile elution was optimized such that only the intact synthetic histone peptide was eluted
from the C18 stage tip, and not the other proteins in the reaction mixture. The samples were then
dried in the speedvac. Once ready to inject in the MS, the samples were reconstituted in 0.1% FA.
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To verify the newly labeled peptide, the samples containing the intact synthetic peptide (after C18
stage tipping) were subjected to derivatization, trypsin digestion, and bottom-up histone peptide
analysis, using the same protocol for acid extracted histones mentioned below.
2.4.2 Acetyl-CoA analysis via Single Reaction Monitoring
Samples were injected onto an Acquity UPLC BEH C18 column (1.7 µm particle size, 2.1
mm x 50 mm, Waters) using a Vanquish UHPLC (Thermo Scientific, San Jose, CA, USA). The
HPLC pumped a constant flow rate of 0.4 ml/min with a programmed gradient from 0.1% to 20%
solvent B (100% acetonitrile) for 1.75 min, followed by a gradient from 20% to 95% over 0.10 min,
then isocratic flow at 95% for 6 min. the UHPLC was coupled online with TSQ Altis Triple
Quadrupole Mass Spectrometer (Thermo Scientific) acquiring data in a Single Reaction Monitoring
(SRM) mode. Q1 and Q3 resolution was set to 0.7 FWHM and collision gas pressure at 1.5 mTorr.
The precursor and product m/z targeted are: 810.130 and 303.140 for light (12C) acetyl-CoA, and
813.100 and 306.100 for heavy (2H) acetyl-CoA at a collision energy of 35 V. The SRM data
obtained was analyzed via Skyline, wherein the peak areas corresponding to 306.100 m/z were
extracted for each sample, which corresponds to the intensity of the heavy acetyl-CoA fragment.
2.4.3 Peptide analysis via Parallel Reaction Monitoring
Samples were injected onto a 75 µm ID × 25 cm Reprosil-Pur C18-AQ (3 µm; Dr. Maisch
GmbH, Germany) nano-column packed in-house using an EASY-nLC nanoHPLC (Thermo
Scientific, San Jose, CA, USA). The nanoLC pumped a flow-rate of 300 nL/min with a programmed
gradient from 5% to 28% solvent B (A = 0.1% formic acid; B = 80% acetonitrile, 0.1% formic acid)
over 45 minutes, followed by a gradient from 28% to 80% solvent B in 5 minutes and 10 min
isocratic at 80% B. The instrument was coupled online with an Orbitrap Fusion (Thermo Scientific,
San Jose, CA, USA) mass spectrometer acquiring data in a targeted MSn method. The mass range
was set to 100-1000 m/z with 54 ms maximum injection time and AGC target of 50000. MS/MS
was performed using ETD fragmentation, with an ETD reaction time of 20 ms and ETD reagent
target of 100000. The data was acquired in the Orbitrap with a resolution of 30k. A mass list table
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was added where m/z of the unmodified and acetylated forms of the synthetic peptide at charge
state of +9 was added. The following m/z were added in the mass list table: 518.6433 (3 ac*),
508.6362 (1 ac*), 503.6326 (unmodified), 513.6398 (2 ac*), 508.3005 (1 ac), 513.304 (1 ac* 1 ac),
517.9719 (1 ac* 2 ac), 512.9683 (2 ac). Charge state of +9 was used since it is the most intense
charge state that the peptide exists in. With the Parallel Reaction Monitoring (PRM) method, the
instrument only targets the specified precursor m/z for fragmentation (Sweredoski et al. 2015). The
PRM data obtained was searched using Byonic and was quantified both manually and via Skyline.
Byonic was used to identify the modifications present in each sample and to identify the sitelocalizing fragments used for quantification. The data was analyzed manually and through Skyline,
wherein 3 site-localizing fragment ions were summed to obtain the intensity of the modified peptide.
2.4.4 Histone extraction, propionylation, and digestion
Histones were extracted by using Nuclei Isolation Buffer (NIB) as previously described
(Sidoli et al. 2016). The cells were incubated in NIB (15 mM Tris-HCl, 15 mM NaCl, 60 mM KCl, 5
mM MgCl2, 1 mM CaCl2 and 250 mM sucrose at pH 7.5; 0.5 mM AEBSF, 10 mM sodium butyrate,
5 µM microcystin and 1 mM DTT added fresh) with 0.2% NP-40 on ice for 5 min. Two rounds of
NIB incubation were performed at a volume buffer:cell pellet of 10:1; the first round 0.2% NP-40
was added to lyse the cell membrane, and the second without NP-40 to remove the detergent from
the nuclear pellet. Each step included centrifugation at 700 x g for 5 min to pellet the intact nuclei.
Next, the pellet was incubated in 0.2 M H2SO4 for 2 hours, and the supernatant was collected after
centrifugation for 5 min at 3400 x g. Finally, histones were precipitated with 33% trichloroacetic acid
(TCA) overnight. The histone pellet was then washed with ice-cold acetone to remove residual
TCA.
Histones were derivatized and digested as previously described (Sidoli et al. 2016).
Histone pellets were resuspended in 20 µl of 50 mM ammonium bicarbonate (pH 8.0), and 10 μl
derivatization mix was added to the samples, which consist of propionic anhydride and acetonitrile
in a 1:3 ratio (v/v), and this was immediately followed by the addition of 5 µl ammonium hydroxide
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to maintain pH 8.0. The sample was incubated for 15 min at 37 °C, dried and the derivatization
procedure was repeated one more time to ensure complete derivatization of unmodified and
monomethylated lysine residues. Samples were then resuspended in 50 µl of 50 mM ammonium
bicarbonate and incubated with trypsin (enzyme:sample ratio of 1:20) overnight at room
temperature. After digestion, the derivatization reaction was performed again twice to derivatize
the N-termini of the peptides. Samples were desalted using C18 stage tips before LC–MS analysis.
2.4.5 Nano LC-MS/MS for bottom-up histone peptide analysis
Samples were resuspended in 0.1% formic acid (FA) and injected onto a 75 µm ID × 25 cm
Reprosil-Pur C18-AQ (3 µm; Dr. Maisch GmbH, Germany) nano-column packed in-house using an
EASY-nLC nanoHPLC (Thermo Scientific, San Jose, CA, USA). The nanoLC pumped a flow-rate
of 300 nL/min with a programmed gradient from 5% to 28% solvent B (A = 0.1% formic acid;
B = 80% acetonitrile, 0.1% formic acid) over 45 minutes, followed by a gradient from 28% to 80%
solvent B in 5 minutes and 10 min isocratic at 80% B. The instrument was coupled online with a QExactive (Thermo Scientific, Bremen, Germany) mass spectrometer acquiring data in a dataindependent acquisition (DIA) mode as previously optimized (Sidoli, Lin, Xiong, et al. 2015; Sidoli,
Simithy, et al. 2015). Specifically, DIA consisted on a full scan MS spectrum (m/z 300−1100)
followed by 16 MS/MS with windows of 50 m/z and detected all in high resolution. The full scan MS
was acquired with a resolution of 35,000 and an automatic gain control (AGC) target of 2´105.
MS/MS was performed with and AGC target of 2´105 using higher-collision dissociation with
normalized collision energy of 27.
DIA data obtained from the bottom-up analysis were searched using EpiProfile 2.0 (Yuan
et al. 2018) and validated manually in Xcalibur (Thermo Scientific, Bremen, Germany). The peptide
relative ratio was calculated using the total area under the extracted ion chromatograms of all
peptides with the same amino acid sequence (including all of its modified forms) as 100%. For
isobaric peptides, the relative ratio of two isobaric forms was estimated by averaging the ratio for
each fragment ion with different mass between the two species. To obtain the % of heavy labeling
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for the yeast experiments, we used the intensity of the heavy labeled form and divided by the sum
of the total intensities of heavy and light peptides within the same amino acid sequence.
2.4.6 Yeast cultures and proteomics
Wild-type and endogenously TAP-tagged (YLR153C from Dharmacon, Horizon Discovery)
Saccharomyces cerevisiae glycerol stocks were streaked onto 2% agar plates containing yeast
nitrogen base (Difco #233520), synthetic complete amino acids mix (Bufferad #S0051) and 2%
glucose. Following overnight incubation at 30°C, starter cultures were inoculated with single
colonies and incubated overnight at 30°C. Secondary cultures were inoculated at OD600=0.2 and
grown at 30°C until they reached OD600=1. Proliferating cultures were pelleted and resuspended in
autoclaved water containing 10 mM D3-acetate (Sigma 176079) to induce quiescence. After 7
days, quiescent cultures were pelleted and washed to remove any residual D3-acetate, and
proliferation was induced by resuspending in liquid media. For preparing yeast cultures for d3acetate analysis, Trichostatin A and nicotinamide (dissolved in DMSO) were added to liquid media
during proliferation for final concentrations of 25 µM and 5 mM, respectively, as been used in the
literature (Bitterman et al. 2002; Martin et al. 2021).
For proteomic analysis, yeast cultures were centrifuged and resuspended in Buffer T [100
mM Tris-HCl pH=9.4, 10 mM DTT] containing PMSF and 100 mM Na-butyrate. Cells were
incubated at 30C for 15 min, pelleted and resuspended in Buffer S [1.2 M sorbitol, 20 mM NaHEPES pH=7.4] containing PMSF and 100 mM Na-butyrate. Cell walls were lysed using 50U of
Zymolyase 100T at 30C for 15 min. Spheroplasting was confirmed under light microscope by mixing
cell lysate with equal volume of 1% SDS. When 80% spheroplasting was reached, lysis was
stopped by the addition of 2x volume ice-cold Buffer SM [2M sorbitol, 20 mM Na-HEPES, 1 mM
MgCl2] containing PMSF and 100 mM Na-butyrate. Subsequent cell lysis was performed using NIB
buffer as described above.
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2.4.7 Chromatin immunoprecipitation followed by sequencing (ChIP-seq)
For ChIPseq analysis, cultures were cross-linked with 1% formaldehyde at RT for 10 min.
Reaction was stopped by adding 135 mM glycine. Cultures were then pelleted, washed and
resuspended in FA-lysis buffer containing protease/phosphatase inhibitors and 10 mM Na-butyrate.
Cells were lysed using a 0.5 mm Zirconia/Silica beads (RPI #9834) in a Mini-Beadbeater high
energy cell disruptor (BioSpec) at 4°C, for 6 times 60 seconds. Samples were cooled on ice for 2
min in-between beatings. Subsequently, lysates were sonicated for 20 min in BioRuptor
(Diagenode), using high setting and 30 seconds ON/OFF cycles. Cell debris was removed by
centrifugation at 10,000 rcf for 15 min at 4°C. Sonication efficiency was confirmed for each sample
by running on 0.8% agarose gel. Equal aliquots of sonicated lysates were used per
immunoprecipitation reaction with 5 ul of H3K9ac antibody (Active Motif 39317), 5 ul H3K14ac
antibody (Active Motif 39697), 5 ul of H3K18ac antibody (Active Motif 39755), 4 ul H3K23ac
antibody (Millipore 07-355), 5 ul H3K27ac antibody (Abcam ab4729), 5 ul of H4K12ac antibody
(Abcam ab46983), 5 ul H4K16ac antibody (Millipore 07-329), 5 ul Acs2 antibody (Thermo MA514810) or 8 ul TAP antibody (Invitrogen CAB1001) preconjugated to Protein G Dynabeads (Life
Technologies). Ten percent of the chromatin was saved as input DNA. ChIP reactions were
incubated overnight at 4 °C with rotation and washed three times in wash buffer.
Immunoprecipitated DNA was eluted from the beads, reversed cross-linked and purified together
with the input DNA. Exactly 20 ng DNA (either ChIP or input) was used to construct sequencing
libraries using the NEBNext Ultra II DNA library preparation kit for Illumina (New England Biolabs;
NEB). Libraries were multiplexed using NEBNext Multiplex Oligos for Illumina (dual index primers)
and single-end sequenced (75 bp) on the NextSeq 550 platform (Illumina) in accordance with the
manufacturer’s protocol.
2.4.8 ChIP-seq analysis
ChIPseq tags generated with the NextSeq 550 platform were demultiplexed using native
applications on BaseSpace and aligned to the sacCer3 reference genome using Bowtie2 v2.3.4.1,
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(parameters—local -X 1000). Aligned tags were filtered for poor alignments using samtools v1.1
(samtools view -q 5 -bS) and merged over NextSeq lanes (samtools merge -n), then filtered for
PCR duplicates using PICARD (java -jar picard.jar MarkDuplicates REMOVE_DUPLICATES=True
ASSUME_SORT_ORDER=queryname). Peaks were detected using MACS2 (callpeak function,
tag size = 75 bp; FDR < 1 × 10−3 with genome size set to -g 12,157,105 and—nomodel set) from
replicate-pooled histone acetylation PTM tags along with treatment-matched input tags as control.
UCSC genome-browser track views were created for ChIP–seq data by first pooling replicates and
generating coverage maps using BEDtools genomeCoverageBed -bg, then adjusting for library
size using the RPM (reads per million) coefficient. The input signal was then subtracted from the
ChIP signal. The resulting tracks were converted from bedGraph to bigWig files using the
bedGraphToBigWig utility in the UCSC Genome Browser. Proximity to ACSS2 peaks was
assessed by expanding all ACSS2 peaks to 2kb around the center, and testing for overlap using
bedtools intersect.
2.4.9 RNA sequencing (RNA-seq)
For RNAseq, cultures were pelleted and resuspended in QIAzol (Qiagen). Cells were lysed
using a 0.5 mm Zirconia/Silica beads (RPI #9834) in a Mini-Beadbeater high energy cell disruptor
(BioSpec) at 4°C, for 4 times 60 seconds. Samples were cooled on ice for 2 min in-between
beatings. RNA was subsequently purified using RNeasy Mini kit (Qiagen). 1 ug of RNA was used
to construct sequencing libraries using the NEBNext Ultra II RNA library preparation kit for Illumina
(New England Biolabs; NEB). Libraries were multiplexed using NEBNext Multiplex Oligos for
Illumina (dual index primers) and single-end sequenced (75 bp) on the NextSeq 550 platform
(Illumina) in accordance with the manufacturer’s protocol.
2.4.10 RNA-seq analysis
All RNA-seq data were prepared for analysis as follows. NextSeq sequencing data were
demultiplexed using native applications on BaseSpace. Demultiplexed FASTQs were aligned by
RNA-STAR

v.2.5.2

to

the

assembly

sacCer3
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(parameters—outFilterType

BySJout—

outFilterMultimapNmax

20

--alignSJoverhangMin

8

--alignSJDBoverhangMin

1

--

outFilterMismatchNmax 999 --alignIntronMin 20 --alignIntronMax 1000000). Aligned reads were
mapped to genomic features using HTSeq v.0.6.1 after merging lanes of NextSeq (parameters -r
pos -s no -t exon -i gene_id). Quantification, library size adjustment and analysis of differential gene
expression was done using DESeq2 and Wald’s test. Overlaps between lists of genes were tested
for significance using a hypergeometric test (phyper() in R).
2.4.11 LC/MS Quantitation of d3-Acetate
Aliquots (25 µL) of each thawed yeast pellet on ice were homogenized in 175 µL of 50/50
water/acetonitrile with 0.3% formic acid at 4 °C using tough microorganism lysing tubes in a
Precellys homogenizer (Bertin Corp., Rockville, MD). Wash and postwash media samples were
aliquoted and prepared without dilution. The input and prewash media samples were diluted 1000x
in deionized water prior to sample preparation. Then, d3-acetate and d3-lactate (internal standard)
were derivatized in 50 µL aliquots of yeast homogenate and media with O-benzylhydroxylamine
through a coupling reaction with 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide at room
temperature for 10 min. This mixture was extracted with 600 uL of ethylacetate with 50 µL of added
deionized water followed by vortexing and centrifuging at 21,000 x g at 4 °C.

Aliquots of

ethylacetate (50 µL) were dried under nitrogen at 30 °C and reconstituted in 500 µL of 50%
methanol in a 96-well plate. Derivatized d3-acetate was quantitated by multiple reaction monitoring
(d3-acetate m/z 169.1 to 91.1, d3-lactate m/z 199.1 to 91.1) with standard calibration curves on an
Agilent 1290 Infinity UHPLC/6495B triple quadrupole mass spectrometer.
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2.5 Supplementary Figures

Supplementary Figure 2.1 H3K18ac* identification from Parallel Reaction Monitoring (PRM)
experiments.
(A) Mass spectrum of the synthetic histone peptide for the in vitro reactions, wherein fragment ions
that correspond to the peptide sequence are annotated. Spectrum was obtained from Byonic. The
red dot on the peptide sequence indicates the heavy acetylation site from synthetic peptide. The
blue dots on the mass spectrum indicate some of the fragment ions that contain K23ac*. (B) Mass
spectrum confirming the identification of K18ac* in the complete rxn sample. The blue dots indicate
fragment ions that contain K18ac*. (C) In vitro reaction showing H3K18ac* produced when all the
3 enzymes are present. P values were calculated using one-way ANOVA with Dunnett’s multiple

42

comparisons test (Complete rxn vs. no CBP: * padj = 0.0129; Complete rxn vs. no ACSS2: * padj
= 0.0104; Complete rxn vs. no HDAC1: ** padj = 0.0076).

Supplementary Figure 2.2 H3K18ac* identification and quantification from bottom-up
peptide analysis.
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(A) Representative chromatogram showing the tryptic peptides generated from digestion of the
synthetic histone peptide. (B) Representative spectra indicating presence of H3K18ac* from the in
vitro reaction that contains all three enzymes present (Complete rxn). Corresponding y-ions that
are unique to H3K18ac* identification are marked in bold. (C) Bar graphs showing the highest
abundance of H3K18ac* in the Complete rxn. Peak areas of the unique y-ions were extracted for
the different in vitro reactions performed. Bar graphs represent mean and SD, n=3/group. P values
were calculated using one-way ANOVA with Dunnett’s multiple comparisons test. ** padj < 0.01,
*** padj < 0.001, **** padj < 0.0001.

Supplementary Figure 2.3 d3-acetate quantification in yeast cells and media by mass
spectrometry.
(A) Bar graph showing d3-acetate concentrations (μM) in the media before and after washing step.
P value (P < 0.0001) was calculated using unpaired T-test. (B) Intracellular d3-acetate
concentrations (nmol/mg protein) when treated with DMSO or HDACi during quiescence exit. P
value (P < 0.001) for DMSO-HDACi samples was calculated by mixed-effects analysis followed by
Sidak’s multiple comparisions test.
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Supplementary Figure 2.4 Methods for yeast Acs2 immunoprecipitation.
Immunoprecipitation showing Acs2 pull-down in S. cerevisiae using (A) Thermo MA5-14810
antibody previously validated in mammalian cells and (B) TAP pull-down in strain with
endogenously TAP-tagged Acs2 (YLR153C).
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Supplementary Figure 2.5 Acs2 is recruited to chromatin during yeast quiescent exit.
(A) Heat map showing untagged Acs2 peaks called in quiescence (n=148) and overlap with TAPAcs2 enrichment. TAP-Acs2 peaks show enrichment at genomic regions of Acs2 peaks called in
different state of quiescence and quiescence exit. (B) Heat map showing untagged Acs2 peaks
called during early quiescence exit at E30 (n=119) and overlap with TAP-Acs2 enrichment. (C)
Heat map showing untagged Acs2 peaks called during late quiescence exit at E240 (n=763) and
overlap with TAP-Acs2 enrichment.
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Supplementary Figure 2.6 Gene ontology analysis of Acs2 peaks.
Top 5 categories in quiescence (A), early quiescence exit (B) and late quiescence exit (C). Number
of Acs2-targeted genes in each category is shown.
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Supplementary Figure 2.7 Acs2 peaks target annotated growth genes.
Venn diagrams showing overlap between annotated growth genes and Acs2 peaks in quiescence
(A), early quiescence exit – 30 min (B) and late quiescence exit – 4 hours (C). Number of
overlapping and non-overlapping genes as well as P values from hypergeometric test are shown.
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Supplementary Figure 2.8 Acs2 preferentially targets induced genes during quiescence
exit.
Acs2 targets a large proportion of 392 annotated growth genes with increased expression in LOG
proliferating compared to quiescence cells (blue). A significantly lower proportion of 392
background genes with no gene expression changes is targeted by Acs2 (grey). Gradient bars
represent gene expression changes and bar graphs show the percentage of genes targeted by
Acs2 throughout the time course.
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Supplementary Figure 2.9 Representative local histone acetylation patterns at genes
induced during quiescence exit.
Gene expression (RNAseq), Acs2 enrichment (untagged and TAP-tagged), H3K9 acetylation and
H3K18 acetylation are shown in quiescent and LOG proliferating cells. (A) Shr3 locus, (B) Yrb1
locus, (C) Pre9 locus.
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CHAPTER 3 Identifying novel ACSS2 interactors during neuronal differentiation

3.1 Introduction
Emerging evidence now directly links metabolism and gene expression through metabolic
enzymes that moonlight in the nucleus and modulate transcription in response to specific intra- and
extracellular inputs (Boukouris, Zervopoulos, and Michelakis 2016). Since these enzymes have the
ability to sense metabolic changes, their ability to localize to the nucleus is an efficient way for cells
to adapt to these changes and survive. Some of the ways by which metabolic enzymes regulate
gene expression is through modulation by their substrates, interactions with other nuclear proteins,
or post-translational modifications (PTMs) that are deposited on metabolic enzymes that alter
structure and function (Xu et al. 2021). Understanding the mechanisms by which nuclear metabolic
enzymes regulate transcription especially during disease progression is critical, as these enzymes
are promising targets for novel therapeutics.
Acetyl-CoA synthetase 2 (ACSS2) is an example of a moonlighting enzyme that has been
found to regulate distinct sets of genes depending on cell states. In glioblastoma cells, ACSS2
localizes to the nucleus during metabolic stress, then binds to the transcription factor TFEB, which
is a master regulator of lysosomal and autophagy genes, leading to histone acetylation at the
promoters of TFEB target genes (Bulusu et al. 2017; Li et al. 2017). This results in increased
lysosomal biogenesis and autophagy, critical for brain tumor cell proliferation. ACSS2 can also
control expression of hypoxia inducible factor 2a (HIF-2a) by generating acetyl-CoA for HIF-2a
acetylation, resulting in increased association between HIF-2a and CBP and upregulation of EPO
gene (Xu et al. 2014). In neurons, nuclear ACSS2 also regulates histone acetylation and expression
of memory-related neuronal genes through association with CBP (Mews et al. 2017). Overall, these
results highlight the importance of nuclear ACSS2 in altering histone acetylation landscape and
transcription of subsets of genes depending on cell type and metabolic state. However, the
mechanisms by which nuclear ACSS2 is recruited to chromatin to elicit its effect remains poorly
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understood, particularly in neuronal differentiation. Previous work demonstrates nuclear ACSS2
associates with CBP, but whether CBP is a key protein critical for interacting with ACSS2 is unclear.
Moreover, it is possible that ACSS2 is interacting with other nuclear proteins to aid in chromatin
recruitment. ACSS2 does not have known DNA- or histone-binding domains, which leads us to
hypothesize that in neuronal development, ACSS2 is associated with specific nuclear proteins that
facilitate the role of ACSS2 in regulating histone acetylation and gene expression.
In this study, we performed a comprehensive analysis in cell lines and in mouse models to
identify candidate ACSS2 interactors, and we identified nucleus accumbens associated 1 (NACC1)
as a potential ACSS2 interactor. We use Cath.a-differentiated (CAD) cells, which express neuronspecific proteins upon differentiation (Qi et al. 1997). Differentiated CAD cells bear processes and
varicosities that resemble neurons, making them a valuable in vitro system to study neuronal
differentiation. Moreover, the differentiation process is metabolically driven via serum deprivation,
indicating a potential role for ACSS2 during differentiation. We explored the nuclear localization of
ACSS2 and NACC1 during differentiation and found that ACSS2 protein levels continuously
increases during differentiation, while NACC1 levels increase at the intermediate time points,
indicating that NACC1 could be important for associating with ACSS2 during the process of
differentiation into neuronal-like cells. Lastly, we show that ACSS2 and NACC1 are co-localized at
specific regions in the genome in differentiated CAD cells, which could demonstrate a novel role of
ACSS2 and NACC1 in regulating subsets of genes during differentiation. Overall, our results
highlight a novel candidate interactor of nuclear ACSS2 in neurons, which could have critical roles
in maintaining neuronal fate.
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3.2 Results
3.2.1 NACC1 as a candidate ACSS2 interactor in Cath.a-differentiated cells and mouse
dorsal hippocampus
To determine potential interactors of nuclear ACSS2, we performed immunoprecipitation
coupled to mass spectrometry (IP-MS) using an antibody that recognizes endogenous ACSS2. We
took time points from undifferentiated, and days 1, 3, and 5 after serum deprivation for the IP-MS
analysis and used nonspecific IgG antibody as a control (Supplementary Figure 3.1A). CAD cells
differentiate into neuronal-like cells after serum deprivation, wherein cells form neuronal projections
and increase expression of neuronal markers (Qi et al. 1997). We observed ACSS2 enrichment at
the IP samples compared to the IgG controls at each time point (Supplementary Figures 3.1B and
3.1C). In the undifferentiated CAD cells, ACSS2 pulled down 202 total significantly enriched
proteins, while the day 5 differentiated cells pulled down 670 significantly enriched proteins (Figures
3.1A and 3.1B). Due to the huge number of proteins pulled down from all IP, we also performed IPMS experiments from mice bearing either WT or KO for ACSS2, and dissecting the dorsal
hippocampus (dHPC), as this region of the brain has been previously studied on the role of ACSS2
and learning and memory (Mews et al. 2017) (Supplementary Figure 3.1D). More importantly, we
can use the KO control to filter out nonspecific proteins that attach to the antibody. We observed
ACSS2 enrichment only in the WT IP samples and not in the KO IP and IgG controls
(Supplementary Figure 3.1E). We detected 170 significantly enriched proteins in the WT IP and
165 proteins in the KO IP (Figures 3.1C and 3.1D). For further analysis, we took the significantly
enriched proteins in the ACSS2 IP from the CAD cells at all 4 time points and overlapped with
proteins identified in the WT mouse IP but not in the KO mouse IP. Interestingly, only three proteins
were identified to overlap from both datasets: ACSS2, NACC1, and VPP1 (Figure 3.1E). Nuclear
accumbens associated 1 (NACC1) was of most interest to us due to its nuclear localization, and it
contains a BTB/POZ domain, which is found in other transcription factors such as BCL6, LRF, and
MIZ-1 (Beaulieu and Sant'Angelo 2011).
53

Figure 3.1 Comprehensive study of ACSS2 interactors in CAD cells and mouse
hippocampus.
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(A) ACSS2 IP-MS in undifferentiated CAD cells. X-axis shows log2 fold change of ACSS2 IP/IgG
control, while y-axis shows -log10 p-value, calculated through two-sided t-test. Each dot
corresponds to a protein. (B) ACSS2 IP-MS in day 5 differentiated CAD cells. (C) ACSS2 IP-MS in
WT mouse dorsal hippocampus. (D) ACSS2 IP-MS in ACSS2 KO mouse dorsal hippocampus. (E)
Venn diagram showing the overlap of enriched proteins from IP experiments from WT mouse (that
is not present in the KO) and CAD cells reveal three proteins that overlap between the two datasets.
This experiment was performed with the help of Desi Alexander.

The NACC1 protein is first discovered overexpressed in the nucleus accumbens of rats
that self-administered cocaine (Cha et al. 1997). NACC1 protein levels appear to remain elevated
even after rats discontinued cocaine use, indicating its role in regulating cocaine-induced
behavioral plasticity (Mackler et al. 2000). NACC1 is also known to interact with CoREST and
HDACs 3 and 4 (Korutla, Wang, and Mackler 2005), which would potentially fit our model as a
candidate ACSS2 interactor, wherein NACC1 recruits ACSS2 at specific regions in the genome for
acetate recycling, thus providing a local acetyl-CoA pool for histone acetylation. From our IP-MS
experiments in the CAD cells, NACC1 is enriched at each time point, through quantification of
abundance and peptide counts (Figures 3.2A and 3.2B). NACC1 is significantly enriched only in
the WT IP from mouse dHPC and not in the KO (Figure 3.2C). We further validated the NACC1ACSS2 interaction by performing co-immunoprecipitation followed by western blotting, wherein we
also found NACC1 enrichment from ACSS2 IP samples (Figure 3.2D). Overall, our comprehensive
analysis of ACSS2 interactors in both cell-based and in vivo systems direct us to a novel candidate
interactor NACC1, which could potentially aid in recruiting ACSS2 to chromatin and mediate local
histone acetylation during neuronal differentiation.
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Figure 3.2 NACC1 as a candidate ACSS2 interactor.
(A) NACC1 enrichment from each IP-MS experiment in CAD cells shows NACC1 enriched only on
the IP samples and not on the IgG controls. Graph is based on log2 normalized intensity of NACC1
protein. (B) NACC1 enrichment from each IP-MS experiment, graphed based on peptide counts
detected for each IP. (C) Scatterplot based from IP-MS experiment in mouse showing NACC1 and
ACSS2 are significant in the WT samples only. X-axis shows the fold change in the WT IP/IgG
control, while y-axis shows the fold change in KO IP/IgG control. Proteins that are marked in blue
are significant (p-value < 0.05) in the WT IP only, while proteins marked in gray are not significant,
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significant only in KO IP, or significant in both WT and KO IP (indicating nonspecific or off-target
interactors). (D) Representative ACSS2 and NACC1 co-immunoprecipitation from differentiated
CAD cells shows that ACSS2 pulls down NACC1.

3.2.2 Nuclear ACSS2 and NACC1 have altered protein levels during CAD differentiation
Since our IP-MS results highlight a novel interaction between ACSS2 and NACC1, we then
tested whether ACSS2 and NACC1 localize to the nucleus at the same time, and whether their
nuclear protein levels change during differentiation. To further investigate the protein dynamics of
ACSS2 and NACC1 in CAD cells, we fractionated cytoplasmic and nuclear compartments and used
mass spectrometry to quantify cytoplasmic and nuclear protein levels. The fractionation step is
critical especially for moonlighting proteins such as ACSS2, since their protein expression levels
could differ between the cytoplasm and nucleus. Our mass spectrometry results show significantly
increased nuclear levels of ACSS2 during differentiation (Figure 3.3A), indicating that nuclear
localization of ACSS2 could be important in transitioning to a differentiated state, potentially through
providing nuclear acetyl-CoA pools in the absence of glucose. However, we found NACC1 protein
levels increase during the intermediate time points only (Figure 3.3B), which could mean an
important temporal role of NACC1 as the CAD cells differentiate. We also assessed protein levels
of other neuronal markers such as synaptophysin, synaptotagmin, and neuromodulin, and we
confirmed significantly increased levels of all proteins in differentiated CAD cells (Figures 3.3C3.3E). Overall, our proteomics analysis confirm that differentiated CAD cells display neuronal-like
properties, and also demonstrate dynamic nuclear ACSS2 and NACC1 protein levels during
differentiation.
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Figure 3.3 Dynamic nuclear ACSS2 and NACC1 protein levels during CAD cells
differentiation.
(A) ACSS2 protein levels increase steadily during differentiation. Graph is based on log2
normalized intensity in undifferentiated cells and during differentiation. P-value is calculated by oneway ANOVA **** padj < 0.0001, *** padj < 0.001. (B) NACC1 protein levels increase during days 2
and 3 of differentiation. (C-E) Neuronal markers synaptophysin (SYPH), synaptotagmin-1 (SYT1),
and neuromodulin (NEUM) increase during differentiation.

3.2.3 NACC1 and ACSS2 co-localize at specific regions in the chromatin
Our IP-MS results indicate NACC1 as a potential nuclear ACSS2 interactor, as we
observed association between ACSS2 and NACC1 in CAD cells and mouse dHPC. To further
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investigate this relationship and genome-wide co-localization, we performed ChIP-seq for NACC1,
ACSS2, and H3K27ac in undifferentiated and day 5 differentiated CAD cells using previously
validated ACSS2 and NACC1 antibodies (Figure 3.4A). ACSS2 and NACC1 are chromatin-bound
in both undifferentiated and differentiated CAD cells, with ACSS2 and NACC1 peaks having the
highest enrichment in differentiated cells (Figures 3.4B and 3.4C). Increased ACSS2 and NACC1
recruitment were observed in genes such as Slc25a25, encoding a mitochondrial soluble carrier
protein, and Ddx17, encoding a RNA helicase protein (Supplementary Figures 3.2A and 3.2B).
25% of ACSS2 peaks were found in proximal promoter regions (<=1kb), while 12% of NACC1
peaks were found in promoter regions (Figure 3.4D). Interestingly, we observed a decrease in
H3K27ac peaks found in proximal promoter regions during differentiation (Figure 3.4D), which
could be due to the transition of CAD cells into a terminal neuronal-like state, wherein global
acetylation decreases and methylation increases (Supplementary Figure 3.3) (Huang et al. 2022;
Podobinska et al. 2017). HOMER motif analysis of ACSS2 and NACC1 peaks in differentiated cells
showed significant enrichment of Phox2a binding motifs (Figure 3.4E). Phox2a, together with its
paralog Phox2b, are homeodomain transcription factors, and Phox2a is highly expressed in
noradrenergic and adrenergic neurons (Coppola et al. 2005). Furthermore, it has been shown that
continued expression of Phox2a genes is important in maintaining noradrenergic neuron
differentiation (Coppola et al. 2010).
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Figure 3.4 ACSS2, NACC1, and H3K27ac ChIP-seq in undifferentiated and differentiated
CAD cells.
(A) Representative ChIP-western blot for ACSS2 and NACC1 in undifferentiated CAD cells. (B)
Peak counts for ACSS2 and NACC1 ChIP-seq in undifferentiated and differentiated CAD cells. (C)
Metaplots showing average ChIP-seq signal over promoter regions in all ChIP experiments
performed. (D) Bar graph showing genomic annotation of ChIP-seq peaks. (E) de novo motif
analysis showing enrichment of ACSS2 (top) and NACC1 (bottom) peaks at Phox2a binding motifs.

We next investigated the correlation between ACSS2 and NACC1 peaks, predicting that
there would be a strong correlation between ACSS2 and NACC1 peaks. We observed a positive
association (R = 0.63) between ACSS2 and NACC1 at ACSS2 ChIP-seq peaks in differentiated
cells (Figure 3.5A). We also observed a positive association between ACSS2 and NACC1 (R =
0.53) at NACC1 ChIP-seq peaks (Figure 3.5B). There is a high overlap between ACSS2 and
NACC1 peaks in differentiated CAD cells (Figure 3.5C), indicating co-localization of ACSS2 and
NACC1 at specific regions of the genome. Gene ontology analysis of ACSS2, NACC1, and
H3K27ac peaks revealed significant enrichment near genes of cytoskeleton, cell-cell adherens
junction, and membrane (Figure 3.5D), which is consistent with morphological changes observed
in differentiated CAD cells. Overall our results indicate co-localization of ACSS2 and NACC1 in
differentiated CAD cells at specific regions in the genome important for cell differentiation and
formation of neuronal processes. Our findings are consistent with previous work wherein ACSS2
regulate subsets of genes during changes in cell states through possible recruitment by NACC1.
We then sought to determine whether ACSS2 and NACC1 targeted genes displayed gene
expression changes during differentiation. We overlapped our ChIP-seq dataset with publicly
available RNA-seq datasets previously published from our lab (Mews et al. 2017) to examine gene
expression changes during differentiation. We observed specific genes targeted by both ACSS2
and NACC1 have increased gene expression during differentiation such as Eif4g2, a translation
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initiation factor that has also been found to be highly expressed in post synaptic densities of mouse
hippocampus (Figure 3.5E) (Distler et al. 2014). Interestingly, EIF4G2 (also known as DAP5, NAT1,
and p97) has been previously found to play a critical role in certain differentiation pathways
(Shatsky et al. 2018). For instance, NAT1-null mouse embryonic stem cells has been shown to be
resistant to differentiation, as NAT1 promoted translation of proteins that induce differentiation
(Sugiyama et al. 2017; Yamanaka et al. 2000). Overall, our findings suggest that ACSS2 and
NACC1 are targeting subsets of genes that are important in cell differentiation.
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Figure 3.5 Overlap between ACSS2 and NACC1 peaks indicate co-localization at specific
genomic regions.
(A) Scatterplot showing the correlation between ACSS2 and NACC1 at ACSS2 ChIP-seq peaks in
differentiated cells. (B) Scatterplot showing the correlation between ACSS2 and NACC1 at NACC1
ChIP-seq peaks in differentiated cells. (C) Venn diagram showing the overlap of peaks between
ACSS2, NACC1, and H3K27ac in differentiated cells. (D) Gene ontology analysis of 142 peaks
found in ACSS2, NACC1, and H3K27ac ChIP-seq. Top 5 most enriched categories are shown. (E)
Genome browser track of ACSS2, NACC1, and H3K27ac ChIP-seq overlapped with RNA-seq from
Mews et al (2017) showing enrichment nearby Eif4g2 gene. ChIP samples are subtracted from the
input as background, as shown on the track label.

3.3 Discussion
Our comprehensive analysis of ACSS2 interactors in CAD cells and mouse dHPC using
mass spectrometry identify NACC1 as a potential ACSS2 interactor. Using the mouse ACSS2 KO
model in conjunction with the in vitro cell-based model provided an optimal negative control for our
affinity enrichment assays. We observed several proteins pulled down from the ACSS2 IP in the
KO mouse, which are due to nonspecific binding to the endogenous ACSS2 antibody and likely are
not interacting with ACSS2. By overlapping the in vivo and in vitro IP results, we were able to filter
out our results stringently and only identify proteins that were identified from both experiments,
leading us to identify NACC1.
To our knowledge, our work is the first to link NACC1 with neuronal differentiation through
association with ACSS2. Similar to ACSS2, NACC1 is also expressed in the brain and is found to
localize in the nucleus (Mackler et al. 2000; Cha et al. 1997). Early studies show that although the
NACC1 POZ/BTB domain is unable to bind DNA by itself, this domain can form heterodimers with
other POZ/BTB proteins such as ZID or BCL-6, which could be the mechanism by which NACC1
regulates gene expression (Mackler et al. 2000). NACC1 has been found to interact with HDAC3
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and HDAC4 in neuronal-like cells, which is in line with our hypothesis that ACSS2-NACC1
interaction could aid in providing nuclear acetyl-CoA pools at specific regions in the genome
(Korutla, Wang, and Mackler 2005). NACC1 has also been shown to interact with Parkin through
its POZ/BTB domain, promoting Parkin and NACC1 aggregation in dopaminergic cells, evident in
postmortem midbrain sections from Parkinson’s disease (PD) patients (Korutla, Furlong, and
Mackler 2014). Our study further supports a potential role of NACC1 in catecholaminergic cells,
particularly during differentiation, as CAD cells are derived from catecholaminergic cell lines. We
predict that NACC1 has distinct nuclear roles during neuronal development and disease
progression, which are mediated depending on its protein interactors.
Nuclear ACSS2 has been found to have various interacting partners depending on cell type
and metabolic state. From our study, we propose that during neuronal differentiation, ACSS2
interacts with NACC1 on chromatin at specific regions to regulate genes that aid in differentiation
process and maintaining morphological changes. From our ChIP-seq data, we found that more
than half of ACSS2 peaks in differentiated cells (174 out of 223 total ACSS2 peaks) overlap with
NACC1. These findings indicate that majority of chromatin-bound ACSS2 is associated with
NACC1 to regulate gene expression at localized regions, perhaps through increasing local acetylCoA production for histone acetylation and gene activation. For instance, we found that ACSS2
and NACC1 are associated nearby the Eif4g2 loci, and this overlaps with increased H3K27ac and
gene expression (Figure 3.5E). We predict that at this region, ACSS2 is providing acetyl-CoA for
H3K27ac, consistent with our previous findings for K27 as an “acceptor” site for acetyl groups to
mediate transcription (Mendoza et al. 2022). On the other hand, we found about a quarter of
NACC1 peaks associated with ACSS2 (174 out of 705 total NACC1 peaks). These results further
suggest to us that some NACC1 protein is important in associating with ACSS2 to chromatin;
however, there could be other ACSS2-independent functions of NACC1 during differentiation.
Furthermore, our ChIP-seq experiments in CAD cells showed lower peak counts for
ACSS2 and NACC1 in differentiated cells. We only obtained 223 ACSS2 peaks and 705 NACC1
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peaks. This is likely not due to technical errors, as we obtained over 32,000 H3K27ac peaks, which
is consistent with previous H3K27ac ChIP-seq data in our lab and others (Nativio et al. 2020; Paauw
et al. 2018), and we have validated both ACSS2 and NACC1 antibodies by ChIP-western blots
(Figure 3.4A). One potential explanation for this could be that there are populations of ACSS2 and
NACC1 that are chromatin-bound, and some that are freely floating in the nucleoplasm not actively
associating with chromatin, or only transiently associating. Thus, chromatin-bound ACSS2 and
NACC1 are important for regulating expression of genes important for neuronal differentiation,
whereas ACSS2-NACC1 that are not chromatin-bound could be working in replenishing global
acetyl-CoA levels in the nucleoplasm. Future work includes interrogating whether ACSS2-NACC1
interaction is direct or whether there are other proteins in this complex.
Moreover, future studies will address the relationship between nuclear ACSS2 and NACC1
during neuronal differentiation. Our results show that ACSS2 and NACC1 are recruited nearby the
Eif4g2 promoter, leading to increased H3K27ac and mRNA expression. EIF4G2 has been found to
play crucial roles during differentiation, since EIF4G2-null mouse embryonic stem cells were unable
to differentiate with retinoic acid (Sugiyama et al. 2017). It remains to be determined whether
knocking down NACC1 prevents ACSS2 recruitment to chromatin and alter cell differentiation.
Additionally, since most of the genomics and proteomics experiments were performed in CAD cells,
future work will be necessary in in vivo models to further characterize the interaction between
ACSS2 and NACC1.
Overall, our findings identify NACC1, a novel candidate interactor of ACSS2 in neuronal
differentiation, and ACSS2 and NACC1 are localized at chromatin in differentiated CAD cells to
regulate subsets of genes important for differentiation. This interaction may be critical in aiding
ACSS2 in providing acetyl-CoA for activating genes important for differentiation and formation of
neuronal processes.
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3.4 Materials and methods
3.4.1 CAD cell culture and differentiation
CAD cells were grown in Dulbecco’s modified Eagle’s medium (DMEM):Ham’s F12 (1:1),
supplemented with 2 mM glutamine, 1% penicillin/streptomycin, and 10% fetal bovine serum (FBS).
To induce neuronal differentiation, sub-confluent CAD cell cultures (50–60%) were transferred to
serum-free medium (DMEM:Ham’s F12 (1:1) supplemented with 2 mM glutamine and 1%
penicillin/streptomycin) and maintained in 15-cm2 culture dishes for 5 days. Upon differentiation,
CAD neurons exhibit morphological changes that are characteristic of neurons.
3.4.2 IP from nuclear extracts in CAD cells
Nuclear extracts were prepared from CAD cells as described previously (Connelly et al.
2018). Cell pellets were washed once with PBS, then 3 ml of buffer A (25 mM HEPES pH 7.8, 5
mM KCl, 25 mM MgCl2, 0.05 mM EDTA,10% glycerol, 0.1% NP-40, supplemented with protease
inhibitor cocktail) was added to resuspend the cell pellet. The cells were incubated on ice for 15
min to lyse the membrane. Then the nuclei were pelleted at 1000xg for 10 mins at 4˚C. 10 µl of the
supernatant (which contains cytoplasmic proteins) was aliquoted for western blotting to confirm
fractionation, and the rest of the supernatant was discarded. The intact nuclei were resuspended
in buffer C (25 mM Tris-HCl pH 7.6, 300 mM NaCl, 1 mM EDTA, supplemented with protease
inhibitor cocktail), adding 2x of the pellet volume (i.e. added 200 µl buffer C to 100 µl of pelleted
nuclei). The nuclei were incubated on ice for 45 min then were pelleted at 16000xg for 5 min. The
supernatant (which contains soluble nuclear proteins) was transferred to a new eppendorf tube.
The protein concentration was determined by Bradford assay.
For the IP experiment, 30 µl Protein G beads (Thermo) were aliquoted to each IP. The
beads were washed twice with 1 ml block solution (0.5% BSA in PBS). Beads were washed by first
adding the 1 ml block solution, then rotating until the sample appears homogeneous, then a
magnetic rack was used to separate the beads from the liquid. Then 5 µg of antibody (ACSS267

abcam ab66038, NACC1- abcam ab29047, IgGR control- abcam ab46540) was added to each IP,
with 250 µl of block solution. The antibody was conjugated to the beads for at least 1 hr by rotating
in 4˚C. After incubation, beads were washed again 3x in 1 ml block solution to wash out unbound
antibodies. Protein lysates were diluted to 0.6 mg/ml in dilution buffer (25 mM Tris-HCl pH 7.6, 150
mM NaCl, 1 mM EDTA) prior to adding to the IP. 600 µg of protein lysates were added to each IP
sample, together with 50 µl of block solution. Samples were incubated overnight by rotating in 4˚C.
After overnight incubation, 20 µl of flowthrough were aliquoted for western blot, while the rest of the
flowthrough was discarded. The beads were washed 2x in dilution buffer, then 2x in 100 mM
ammonium bicarbonate (ABC). After the series of washes, beads were resuspended in 50 µl ABC
to prepare for MS analysis. 10 mM DTT was added to each sample to reduce disulfide bonds, and
samples were incubated for 30 min at 55˚C. 25 mM iodoacetamide was added to each sample to
alkylate cysteine residues, preventing disulfide bonds from reforming. Samples were incubated in
the dark at room temperature for 1 hr. Afterwards, on-bead trypsin digestion was performed by
adding 1.5 µg trypsin per sample, together with 5% acetonitrile. Samples were incubated overnight
at room temperature with shaking. After digestion, the digested peptides (which are in the
supernatant) were collected and dried in the SpeedVac. Then samples were desalted using C18
StageTips as previously described (Lin and Garcia 2012). After desalting, samples were
resuspended in 12 µl of 0.1% formic acid (in LC-MS grade water), 4 µl was aliquoted for peptide
quantification (Pierce Quantitative Colorimetric Peptide Assay, Thermo), while the rest were
transferred to autosampler vials for MS analysis.
3.4.2 Nano LC-MS/MS for IP analysis
Samples were loaded onto a 17-cm in house C18 column (Reprosil-Pur) using a Dionex
LC (Thermo Scientific) coupled to a QE-HF orbitrap mass spectrometer (Thermo Scientific).
Peptides were eluted over 90-minute gradient from 5-35% solvent B (A = 0.1% formic acid, B =
80% acetonitrile, 0.1% formic acid), the flow rate was set to 300nl/min. Data was obtained in data
dependent mode (DDA), the MS1 was acquired over 300-1200 m/z with a resolution of 60,000,
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AGC target of 5e5, and maximum injection time of 100 ms. For the MS2, the top 25 most intense
ions were selected for MS/MS by high-energy collision dissociation (HCD) at 27 NCE, with a
resolution of 30,000, AGC target of 1e5, and maximum injection time of 150 ms. Raw files were
processed using MaxQuant (v 1.6.0.16) (Cox and Mann, 2008) using M. Musculus database
(Uniprot, April 2017). For MS/MS database search the precursor mass tolerance was set to 4.5ppm
and the product mass tolerance to 0.5 Da. Two trypsin missed cleavages were allowed,
carbamidomethyl (C) was set as static modification, oxidation (M) as well as acetyl (protein N-term)
were selected as variable modifications. Proteins were quantified using label-free quantification
(iBAQ), and finally, protein false discovery rate (FDR) were filtered for < 0.01.
3.4.3 Nuclear extract preparation for IP from ACSS2 WT/KO mouse dHPC
Samples were prepared from whole mouse hippocampus as follows: the hippocampus was
dissected bilaterally from WT and KO mice. Tissue chunks were crosslinked for 10 min at room
temperature using 1% formaldehyde in 1 ml PBS and quenched with 2.5 M glycine for 5 min. Then
the brain chunks were dounced using 2 ml dounce homogenizer in 1 ml of 0.25 M Sucrose/TKM
buffer with protease inhibitors and sodium butyrate (10 strokes pestle A, 20 strokes pestle B).
Lysates were transferred to new Eppendorf tubes and left on ice for 10 min. Then the nuclei were
pelleted at 5000xg for 4 min at 4˚C. The supernatant was discarded, and the nuclei were
resuspended in 700 µl of lysis buffer 3 supplemented with protease inhibitors and sodium butyrate.
Chromatin was sheared using the bioruptor for 15 min using high setting. The samples were
centrifuged for 16000xg for 10 min at 4˚C to pellet debris. The supernatant (conaining crosslinked
nuclear lysates for IP) was transferred to a new tube. Protein concentration of lysates was
determined using Bradford assay. The IP experiment was performed similar to the CAD cells as
mentioned above.
3.4.4 Cytoplasmic/nuclear fractionation for proteomics analysis
Cell pellets were first washed in PBS then were resuspended in lysis buffer (20 mM HEPES
pH 7.9, 150 mM NaCl, 0.5 mM MgCl2, 0.5% NP-40, 10% glycerol, supplemented with protease
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inhibitors), adding 3x the pellet volume (i.e. add 1.5 ml lysis buffer to 500 µl pellet). Cell pellets were
incubated on ice for 5 min, then they were centrifuged for 20 min at 4˚C at 16000xg. The
supernatant (containing cytoplasmic proteins) were transferred to a new Eppendorf tube. The nuclei
pellet was rinsed 2-3x with 500 µl of PBS. Then the nuclei pellets were resuspended in 50 mM
ABC, then the samples were sonicated using the bioruptor for 5 min (making sure samples stay
cold). Protein concentrations from cytoplasmic and nuclear fractions were determined using
Bradford assay. 50 µg of lysates were aliquoted for MS analysis.
Samples were prepared for MS analysis as follows: 50 µg of protein was adjusted to a final
volume of 50 µl using 50 mM ABC. 10 mM DTT was added to each sample, then all samples were
incubated at 55˚C for 20 min. 25 mM iodoacetamide was added to each sample, then all samples
were incubated for 30 min in the dark. Afterwards, 6 volumes of pre-chilled acetone were added to
each sample. Each tube was inverted multiple times to mix. Samples were placed in -20˚C for
overnight protein precipitation. After overnight incubation, samples were centrifuged at 8000xg for
10 min at 4˚C. The supernatant was transferred to a new Eppendorf tube, carefully not disturbing
the pellet. The pellets (which contains precipitated proteins) were air dried for 10 min. Once dry,
the pellets were resuspended in 50 µl of 50 mM ABC, then 1.5 µg of trypsin was added to each
sample. Samples were digested overnight at 37˚C while shaking. After overnight incubation,
samples were desalted using StageTips as previously described (Lin and Garcia 2012). The
samples were resuspended in 30 µl of 0.1% formic acid, then 5 µl was aliquoted for peptide
quantification (Pierce Quantitative Colorimetric Peptide Assay, Thermo)
3.4.5 Nano LC-MS/MS for proteomics analysis
Cytoplasmic and nuclear fractions were resuspended in buffer A (0.1% formic acid) and 1
ug was injected and analyzed by nanoLC-MS/MS with a Dionex-nanoLC coupled to an QE-HF
(Thermo Fisher Scientific). The column was packed in-house. The samples were eluted over a 90
min gradient from 5-35% solvent B (A = 0.1% formic acid; B = 80% acetonitrile, 0.1% formic acid).
The flow rate was at 300 nL/min. Data were acquired using a data-independent acquisition method
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(Pino et al. 2020), consisting of a full scan MS spectrum (m/z 385−1015) performed in the Orbitrap
at 60,000 resolution with an AGC target value of 1e6, followed by 25 overlapping MS/MS windows
of 24 m/z using HCD fragmentation and detection in the orbitrap at 30,000 resolution. HCD collision
energy was set to 27, AGC target at 1e6, and maximum inject time at 60 ms. To build a
chromatogram library for data analysis, a pooled sample was generated for each library (Searle et
al. 2018). In our experiment, we made 6 libraries: cytoplasmic, nuclear, undiff cytoplasmic, diff
cytoplasmic, undiff nuclear, and diff nuclear. 1.5 ug of each sample was combined, and several
data-independent acquisition runs that were identical to the method just described were acquired.
With the pooled samples, the full MS for each method covered a range of only 110 m/z with 25
overlapping MS/MS windows of 4 m/z each. For data analysis, .raw files were converted to .mzML
using MSConvert (Chambers et al. 2012). Then a chromatogram library was built using Walnut in
EncyclopeDIA, and data was searched from the chromatogram library using EncyclopeDIA (Searle
et al. 2018).
3.4.6 Chromatin immunoprecipitation followed by sequencing (ChIP-seq)
ChIP-seq was done as previously reported (Lin-Shiao et al. 2018). Briefly, cells were fixed
in 1% formaldehyde in PBS for 10 minutes, the fixation was quenched with 125mm glycine for 5
minutes. Chromatin was sonicated with a S220 Focused-ultrasonicator (Covaris) for 15 min and
immunoprecipitated with either ACSS2, NACC1, or IgGR antibodies. Antibodies were conjugated
to protein G Dynabeads (Thermo). Eluted samples were reverse cross-linked overnight at 65°C,
and DNA as purified after treatment with RNAse (Thermo) and Proteinase K (Thermo). Purified
DNA was quantified using Qubit dsDNA kit (Thermo) and 50ng was used to prepare sequencing
libraries. Input samples were also included and prepared using the same protocol. NEBNext Ultra
DNA library kit from Illumina (New England Biolabs) was used to prepare the libraries and the
quality was assessed by Agilent BioAnalyzer 2100 (Agilent). Quantification was done using
NEBNext library Quant kit (New England Biolabs). Paired end sequencing was performed on a
NextSeq 500 platform.
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3.5 Supplementary Figures
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Supplementary Figure 3.1 ACSS2 IP-MS in CAD cells and mouse hippocampus.
(A) Principal component analysis on IP-MS samples in CAD cells. (B) ACSS2 enrichment from IPMS experiments in CAD cells show ACSS2 is only enriched in the IP samples and not in the IgG
control. Graph is shown as a log2 normalized intensity. (C) ACSS2 peptide counts is the highest in
the IP samples and not in the IgG controls. (D) Principal component analysis on IP-MS samples in
mouse hippocampus. (E) ACSS2 enrichment from IP-MS experiments in mouse hippocampus
show ACSS2 is highly enriched only in the ACSS2 IP in WT tissues.
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Supplementary Figure 3.2 Genome browser tracks showing ACSS2, NACC1, and H3K27ac
co-localization nearby two representative genes.
(A) Slc25a25 and (B) Ddx17.
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Supplementary Figure 3.3 Heatmap showing histone modifications in CAD cells, showing
that histone methylation increases during differentiation.
Abundance values are normalized by z-scores.
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CHAPTER 4 Bullet points to evaluate the performance of the middle-down proteomics
workflow for histone modification analysis

4.1 Introduction
Mass spectrometry (MS) is one of the most commonly used approach to identify and quantify
histone post-translational modifications (PTMs). Given its high mass accuracy and versatility,
quantification of over 200 modified species can easily be achieved in one hour with commonly used
online liquid chromatography-MS (LC-MS). In the shotgun approach, or bottom-up MS, histones
are propionylated and digested with trypsin, typically generating peptides of between 4-20 amino
acids. A second round of propionylation is then needed to derivatize the newly generated N-termini
(Karch et al. 2013; Sidoli et al. 2016). Bottom-up MS is the most common workflow for histone
PTMs identification and quantification. It can be performed with low-resolution instruments using
collision induced dissociation (CID) (Karch, Zee, and Garcia 2014) or higher energy collisional
dissociation (HCD) (Figure 4.1). In triple quadrupole mass spectrometers, for example, the data is
acquired using multiple reaction monitoring (SRM) where transition peptides of a known mass are
used for quantification (Darwanto et al. 2010; Zheng, Huang, and Kelleher 2016). Histone peptides
have unique challenges for MS detection due to the presence of isobaric or “nearly” isobaric forms.
For instance, acetylation on lysine residues generates a mass shift of 42.01 Da, while a
trimethylation 42.04 Da; this mass difference can be distinguished either by very high resolution
(>60,000) or retention time shift (acetylation is more hydrophobic). In the case of completely
isobaric forms, the most commonly used approach is quantifying the intensity of MS2 fragment ions
(Marczak, Znajdek-Awizen, and Bylka 2016; Zheng, Huang, and Kelleher 2016). Interestingly,
differential ion mobility has shown promising results as well, in particular with longer polypeptide
sequences (Yuan et al. 2015). MS2 acquisition to discriminate isobaric forms should be performed
in a way that the entire elution profile contains MS2 data points; a single MS2 could be misleading,
if the two isobaric forms do not completely co-elute. MS2 can be then performed either using
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targeted methods (SRM or targeted product ion scan) or with windows-based data independent
acquisition (DIA) (Marczak, Znajdek-Awizen, and Bylka 2016), where large isolation windows are
used to fragment all signals independently of the ions present in the MS1 event (Janssen, Sidoli,
and Garcia 2017). Since ions are being selected for fragmentation at each duty cycle, MS2-based
extracted ion chromatograms are more accurate, making the experiment feasible even with lowresolution mass analyzers such as ion traps (Sidoli, Simithy, et al. 2015).

Figure 4.1. Current workflows to analyze histone post-translational modifications.
In bottom-up analysis (top arrow) after trypsin digestion, samples are analyzed using
reversed-phase chromatography (RPC). As for fragmentation type in bottom-up studies, collisioninduced dissociation (CID) is typically used. In the middle arrow, middle-down strategy is presented,
wherein samples are digested using GluC instead of trypsin. Histone tails are further separated
using WCX-HILIC and fragmented for identification using electron transfer dissociation (ETD) or
ultraviolet photodissociation (UVPD). The top-down approach is represented by the bottom arrow.
Typically, histones are purified using reverse-phase liquid chromatography. For top-down analysis,
RPC or WCX-HILIC is used. The fragmentation is done similarly to middle-down.
For studies of PTMs distant from each other in the sequence, top-down and middle-down
approaches are needed. In top-down MS, histones are analyzed without digestion, utilizing
electron-transfer dissociation (ETD) and more recently ultraviolet photodissociation (UVPD) (Greer
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and Brodbelt 2018). This method greatly benefits from separating individual histone classes using
reversed-phase chromatography (RP-HPLC) prior to MS injection to reduce the complexity of the
spectra. In some cases, an additional fractionation step is needed before MS analysis (Wang, Holt,
and Young 2018). After fractionation, individual histones are analyzed by LC-MS either using weak
cation exchange chromatography (Tian et al. 2012; Tvardovskiy et al. 2015), C18-based
chromatography, or directly infusing the sample into the mass spectrometer (Zheng et al. 2016). In
top-down MS for histone analysis, data is acquired using data dependent acquisition (DDA) and
only charges +9 or higher are selected for fragmentation (Molden and Garcia 2014). Although the
entire histone can be analyzed using top-down MS, this approach still has several limitations. First,
the up-front requirement of sample fractionation is not only time-consuming but requires large
amounts of starting material (usually hundreds of micrograms of purified histones). Moreover,
chromatography is very limited in separating intact histones, leading to very complex mixed MS2
spectra containing isobaric forms, nearly-isobaric forms (acetylated vs trimethylated peptides) and
even histone variants due to their sequence homology (Onder et al. 2015). A few laboratories have
developed methods to deconvolute the complexity of those spectra e.g. (Dang et al. 2016;
Pesavento, Mizzen, and Kelleher 2006), but both identification and quantification still remain
challenging.
Middle-down MS strategy has become the method of choice to study combinatorial histone
PTMs. In this workflow, histones are most frequently digested with the protease GluC, producing
N-terminal peptides (“tails”) 50-60 residues long that can be further analyzed by LC-MS. In middledown experiments, histone tails are often separated using weak cation exchange columns in the
hydrophilic interaction chromatography mode (WCX-HILIC). Since histone tails are highly charged
molecules, typical fragmentation (HCD or CID) strategies do not produce enough fragment ions to
allow precise localization of PTMs. For this reason, Electron Transfer Dissociation (ETD) is the gold
standard for histone middle-down analysis, with UVPD emerging as a potential alternative (Greer
et al. 2018). Middle-down analysis can be combined with metabolic labeling to answer questions
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regarding catalysis rates of PTM formation (Sidoli et al. 2017). With this method, it is possible to
quantify the coexistence frequency of two or more PTMs and investigate the likelihood of two or
more modifications being on the same tail using normalization methods like the interplay score
(Schwammle et al. 2016; Schwammle et al. 2014). Over the past few years, middle-down MS
analysis has grown in popularity, yet it is still limited in reproducibility and robustness compared to
bottom-up (Sidoli and Garcia 2017b). Moreover, data analysis and instrument setup do not have
well-defined benchmarks, creating communication barriers when defining satisfactory vs.
unsatisfactory performance. We present a detailed protocol to perform middle-down MS of
hypermodified histone tails, focusing on tips and benchmarks on how to evaluate adequacy of
performance of this workflow.
4.2 Results
4.2.1 Utilization of porous graphitic carbon (PGC) in the desalting step
Middle-down MS generates histone peptides spanning the entire N-terminal tail, which is
important in quantifying combinatorial modifications along the tail. As the histone tails generated
have high hydrophilicity and basicity (due to the basic groups from lysine and arginine residues),
WCX-HILIC is commonly used in separating the different modified forms (Young et al. 2009).
Peptides are retained both through electrostatic attraction and hydrophilic interaction. A decreasing
gradient of ACN tunes down the hydrophilic interaction (Jensen et al. 2013) while a decreasing pH
gradient uncharges the polyaspartic acid-coated PolyCAT A stationary phase, tuning down the
electrostatic attraction. The eluting peptides are then directly introduced via nanoelectrospray
ionization into the mass spectrometer equipped with electron transfer dissociation (ETD)
fragmentation. Using ETD for MS2 fragmentation is highly efficient for highly charged intermediatelength histone peptides, resulting in high sequence and PTM coverage (Cristobal et al. 2017; Good
et al. 2007).
We demonstrate that adding porous graphitic carbon (PGC) (Bapiro, Richards, and Jodrell
2016; West, Elfakir, and Lafosse 2010) on top of the C18 plug helps reduce sample loss during the
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desalting process, as it has higher capacity and more efficient binding for polar molecules than C18
material (Figure 4.2A). A significantly larger number of identified H3 combinatorial modifications
were identified in samples desalted using Stage tips containing PGC as bulk resin, suggesting that
PGC complements the retention from C18 material. In summary, identification and quantification of
about 200 histone codes from histone H3 is considered a good performance. Importantly, the
washing step prior to the elution should be performed with MS grade water without acids to avoid
acidifying the sample in the elution buffer.

Figure 4.2. StageTip comparison to assess sample loss prior to MS/MS analysis.
(A) Number of identified proteoforms from histone samples desalted via RPC StageTip with or
without additional PGC resin. A total of 3 replicate runs were performed. * Indicates two-tailed ttest with a p-value < 0.05. (B) Pearson correlation of proteoforms identified from the different
StageTip runs; BU denotes histone samples analyzed by bottom-up proteomics. The two middledown runs have the higher correlation, but when compared to bottom-up analysis, PGC + C18 stage
tips showed higher correlation than C18 only. Additionally, PGC + C18 also shows lower coefficient
of variation (CV) values (C).
4.2.2. Re-evaluation of WCX mobile phase
In WCX-HILIC chromatography of histones, buffer A usually consists of 75% acetonitrile
with 20mM (overall) propionic acid pH 6 adjusted with ammonium hydroxide (NH4OH), while buffer
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B is 25% acetonitrile at pH 2.5, adjusted with formic acid (Young et al. 2009). One of the biggest
challenges in middle-down proteomics is the reproducibility of the chromatography and tedious
work in buffer preparation. Moreover, laboratories often do not have a dedicated LC system just for
middle-down analysis. With this in mind, we recommend using 0.1% formic acid (FA) as buffer B,
which is frequently buffer A in C18-based chromatography. This minimizes time in buffer preparation
and changes in LC configuration. For buffer A, we now recommend adjusting the pH using
ethylenediamine (EDA) instead of NH4OH. Compared to ammonium ion, ethylenediammonium ion
is a better-hydrated anion (Cohen, Liu, and Gong 2012) and forms better-hydrated ion pairs with
the acidic residues in histones (Alpert 2018). As a result, the peptides are better retained in the
HILIC mode, and the selectivity for acidic residues increases relative to that of the numerous basic
residues. This results in the interesting change in selectivity seen in Figure 4.3A. More variant
sequences are identified as well (Figure 4.3B). The use of EDA instead of NH4OH also results in
more reproducible quantification as measured from the coefficient of variation (Figure 4.3C)

Figure 4.3. Evaluation of middle-down chromatography.
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(A) Chromatogram showing separation of different acetylation variants. In the top panel, the buffer
contained EDA while NH4OH was used in the bottom panel. (B) Number of proteoforms identified
using different bases to adjust the pH of buffer A. (C) Violin plots representing the distribution of
CV for each condition (three replicate runs).
4.2.2. Determining proper fragmentation
Proper fragmentation is key to assign PTMs unambiguously. After data acquisition, the
fragmentation efficiency can be determined by looking at the MS2 spectra in Mascot. Fragment ion
coverage is key for proper assignment of PTMs. An example of ETD fragmentation showing
sufficient (A) and insufficient (B) MS/MS ion coverage is shown in Figure 4.4. Electron transfer
without dissociation (“ET no D”) will result in insufficient fragmentation. In this case, at the MS2
level, the parent ion is the most abundant species, followed by the reduced charged precursor
(Figure 4.4C). In this case we recommend (1) verifying the intensity of the fluoranthene reagent in
the mass spectrometer, making sure that it is higher than 5E6; (2) using angiotensin reagent to
make sure that the instrument is performing optimally, and; (3) calibrating the ETD parameters and
making sure that negative electron multipliers are calibrated.

Figure 4.4. Evaluation of ETD fragmentation.
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Representative MS2 spectra showing sufficient (A) vs insufficient (B) fragmentation. Figure C
shows electron transfer with no dissociation, a common problem when using ETD fragmentation.
4.2.2. Data visualization and interpretation
After data processing, middle-down experiments usually yield at least 150 IDs. As shown in
Figure 4.5A, most peptides have 2 or 3 PTM modifications. As shown in Figure 4.5B, over 100 coexistence frequencies for binary PTMs were identified in this study, indicating high quality data.

Figure 4.5. Assessing data quality.
(A) Number of peptides containing multiple PTM modifications on the same tail. (B) Frequency of
binary PTMs identified with the combinations listed. Over 100 coexisting binary PTMs should be
obtained in a successful middle-down experiment.

To visualize co-existing PTMs and their frequencies, we generated a ring plot using the
interplay score as shown in Figure 4.6A. The interplay score was calculated using the relative
abundance of a given binary modification (ab) using the following equation:
𝐼𝑛𝑡𝑒𝑟𝑝𝑙𝑎𝑦!" = 𝑙𝑜𝑔#

𝐹!"
𝐹! ∗ 𝐹"

Here, Fab is the observed abundance of the binary modification and Fa*Fb is the predicted
frequency of a given combinatorial modification, which is a function of the abundance of each
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individual PTM (Schwammle et al. 2014; Sidoli and Garcia 2017a). Histone modifications that are
never found on the same tail do not have a calculated interplay value. If two PTMs are mutually
exclusive, then the interplay score will be negative, while positively related modifications will yield
a positive score. The resulting table was formatted and visualized using CytoScape (Shannon et
al. 2003). This type of plot permits color-codes positive and negative interplays; additionally, the
interplay score can define by the width of the lines (Figure 4.6A). For simplicity we only showed 50
interplay scores in the ring plot. Relative abundance can also be visualized using bar graphs as
shown in Figure 4.6B.
B

A

Figure 4.6. Visualization of middle-down data.
Figures A and B show examples of data representation, visualized as a ring plot (A) using
Cytoscape or bar graph (B) using Excel. In the ring plot, the green lines indicate negative interplay
and the magenta lines indicate positive interplay. The thickness of the lines is directly related to the
value of the absolute interplay score: the thicker the line, the higher the interplay score.
4.3 Discussion
Middle-down proteomics has emerged as the method of choice to study combinatorial
histone post translational modifications (PTMs). In the common bottom-up workflow, histones are
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digested into relatively short peptides (4-20 aa), separated using reversed-phase chromatography
and analyzed using typical proteomics methods in mass spectrometry. In middle-down, histones
are cleaved into longer polypeptides (50-60 aa) mostly corresponding to their N-terminal tails,
resolved using weak cation exchange-hydrophilic interaction liquid chromatography (WCX-HILIC)
and analyzed with less conventional mass spectrometry, i.e. using Electron Transfer Dissociation
(ETD) for analyte fragmentation. Middle-down is not nearly as utilized as bottom-up for PTM
analysis, partially due to its limited reproducibility and robustness. This has also limited the
establishment of rigorous benchmarks to discriminate good vs poor quality experiments. Here, we
describe critical aspects of the middle-down workflow, specifically, we tested the use of porous
graphitic carbon (PGC) during the desalting step, demonstrating that desalting using only C18
material leads to sample loss. We also tested different salts in the WCX-HILIC buffers for their
effect on retention, selectivity, and reproducibility of analysis of variants of histone tail fragments,
in particular replacing ammonium ion with ethylenediammonium ion in buffer A. These substitutions
had marked effects on selectivity and retention. Some significant new procedures and observations
are as follows:
1.

During the desalting step, deposition of PGC resin on top of the C18 disk significantly
increased the number of isoforms identified (Figure 4.2A). This reflects PGC’s
complementary selectivity, especially for retention of polar solutes (Lunn, Yun, and
Jorgenson 2017).

2. One of the major limitations of this type of experiment is the lack of reproducibility, mainly
due to properties of the chromatography. Substitution of ethylenediammonium ion for
ammonium ion in Buffer A results in better reproducibility. In addition, the number of H3
isoforms identified is higher and there is better separation of H3 acetylation variants (Figure
4.3). This has interesting implications for the mechanism of the chromatography. When
ammonium ion is used, the varied affinity for the numerous positional and methylation
variants of various PTM’s results in appreciable overlap of forms differing in the number of
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acetylated lysine residues. Elimination of that overlap with ethylenediammonium ion
implies a shift in chromatographic selectivity to favor variants differing in absolute charge.
Here we have highlighted the utilization of 0.1% FA as buffer A for HILIC-based
chromatography. We also provide detailed information on how to evaluate the performance of
middle-down analysis at the MS/MS level. Examples are provided of successful (Figure 4.4A) and
unsuccessful (Figure 4.4B) fragmentation, and possible reasons for insufficient fragmentation
(Figure 4.4C).

4.4 Materials and methods
4.4.1 Sample preparation and digestion with GluC
All the protocols and experiments presented here were performed utilizing a bovine histone
mixture, purchased from Sigma-Aldrich. The histone samples were digested with GluC to generate
large polypeptides spanning the first 50 amino acids of histone H3. To avoid subjecting GluC
solutions to freeze-thaw cycles, aliquots of 5 µg of were lyophilized using a vacuum centrifuge, and
these dried aliquots can be stored at -20° C for several months. In this study, 50 µg of histones
were digested in 5mM ammonium acetate pH 4.0 with GluC (1:20 ratio of enzyme:histone)
overnight at room temperature. The digestion can be incubated for 6 hours at 37° C or overnight at
room temperature. Importantly, GluC is active at around two different pH; at pH 8, it cleaves at the
C-termini of glutamic acid residues (E), while at pH 4 it cleaves at the C-termini of aspartic and
glutamic acid (DE). We recommend utilizing pH 4.0, because aspartic acid residues are not present
in the histone tail and lower pH minimizes deamination events (N à D or Q à E).
4.4.2 Sample desalting by StageTips
The StageTips were made in-house, and all solvents listed used here were MS grade. The
StageTips were made by punching C18 extraction disks using a P1000 pipette tip, and then housed
into a p200 pipette (Lin and Garcia 2012). Approximately 70 µl of Porous Graphitic Carbon resin
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(PGC, HyperCarb® Thermo) were added on top of the C18 disk. Before adding it to the C18 disk
the PGC resin was mixed 1:1 with 100% acetonitrile. StageTips were centrifuged for 2 minutes at
200g, once the ACN passed through the C18 disk, and the flow through was discarded. Next,
StageTips were washed twice with 50 µl of 0.1% TFA. Samples were resuspended in 100 µl of
0.1% TFA and loaded into the StageTips. After 2 washes with 50 µl of water, samples were eluted
twice into a new microcentrifuge with 50 µl of elution buffer, which is the same as the WCX-HILIC
buffer A (70% acetonitrile, 20 mM propionic acid pH 6.0, adjusted using ethylenediamine). The
eluted samples are now ready for MS analysis.
4.4.3 Nano LC (nLC) configuration for middle-down
After desalting, samples (2 µg) were loaded onto a 75um ID silica capillary packed with
PolyCAT A (PolyLC Inc; Columbia, MD), 1.9-µm, with 1000-Å pores. Histone tails were eluted over
90 minute using a non-linear gradient from 0-72 %B in 2 min, followed by 72-85% B. Buffer A
consisted of 70% ACN, 20mM propionic acid pH 6 (using ethylenediamine to adjust pH), Buffer B
was 0.1% FA solution in water. The flow rate used to deliver the gradient was set to 300 nl/min. All
buffers were prepared using MS grade solvents.
4.4.4 MS/MS analysis
Data was acquired in data dependent mode (DDA) using a hybrid Orbitrap Fusion mass
spectrometer (Thermo). We programmed the MS acquisition method using high resolution for both
full MS (MS1) event and tandem MS (MS2) scans. A full mass spectrum was acquired at a narrow
scan range (665-705 m/z) to select for histone H3 peptides with a charge state of +8, as these
histone peptides have the most intense ionization frequency, and the H3 peptides are the least
crowded. Additionally, a charge gate filter was also added to include charge state +8 to target for
fragmentation. Dynamic exclusion was used to exclude peaks for 2 sec so more data could be
obtained on less intense peaks that co-elute. More detailed parameters for the MS1 and MS2 scans
are listed in Table 1. Ion transfer tube temperature was set to 300° C and the spray voltage was
set to 2.3kV. Finally, 3 microscans were averaged to obtain a high-resolution spectrum.
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Table 1. Mass spectrometer parameters for precursor and fragment ions identification.
Parameter

MS 1

MS 2

Resolution

Orbitrap - 120000

Orbitrap - 30000

Fragmentation

-

ETD
20ms reaction time

AGC target

2.0e5

2.0e5

Ion injection time

100

800

4.4.5 Data analysis
After data acquisition, MS raw files were searched using Mascot 2.5 against histone
databases, UniProt (2014). Before the database search, the MS raw files were deconvoluted using
Xtract (Thermo). For database search, dynamic modifications: Acetylation (K), mono and
dimethylation (RK), and trimethylation (K) were included. The mass tolerance was set to 2.1 Da for
the precursor ions and 0.01 Da for the fragment ions. The resulting Mascot search files were
downloaded as comma separated values (.csv) and the query information included. The csv file
was further processed using our in-house software IsoScale (Greer et al., 2018) freely available at
http://middle-down.github.io/Software/. IsoScale discards ambiguously mapped PTMs, providing
highly confident quantification and identification.

87

CHAPTER 5 Conclusions and future directions

5.1 Summary and main findings
This dissertation presents the work I have completed to demonstrate the role of nuclear
ACSS2 in maintaining histone acetylation (Chapter 2), identify binding partners important for
recruitment to chromatin (Chapter 3), as well as improve current middle-down workflows for
quantifying combinatorial histone PTMs (Chapter 4). Recent studies have highlighted the
intersection between metabolism and epigenetics through metabolic enzymes that moonlight in the
nucleus to regulate gene expression by binding to chromatin (Egervari, Glastad, and Berger 2020;
Li et al. 2018; Boukouris, Zervopoulos, and Michelakis 2016). Presence of metabolic enzymes in
the nucleus can control metabolite concentrations such as acetyl-CoA and S-adenosyl methionine,
which are also critical cofactors for histone- and DNA-modifying enzymes. ACSS2 has been found
to localize to the nucleus during metabolic changes such as nutrient deprivation, wherein it
maintains histone acetylation by generating nuclear acetyl-CoA pools (Li et al. 2017; Li, Qian, and
Lu 2017). It is proposed that nuclear ACSS2 uses acetate released from histone deacetylase
reactions to generate acetyl-CoA for histone acetylation. Moreover, nuclear ACSS2 does not
contain known histone- and DNA-binding domains, so it is likely to interact with other transcription
factors or chromatin modifiers to mediate their effects to chromatin. MS-based approaches have
been highly used in investigating epigenetic mechanisms, not only for detecting and quantifying
histone modifications, but also for tracking PTMs or small molecules. In my dissertation, we applied
MS and genomics-based approaches to investigate the role of nuclear ACSS2 in maintaining
histone acetylation.
In the second chapter of this dissertation, using in vitro and in vivo approaches, we query
whether intact acetate can be directly transferred between histone residues and whether ACSS2
can facilitate local transfer important for rapid transcriptional activation (Mendoza et al. 2022). Our
work has demonstrated the following main findings:
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1. We developed an in vitro assay to detect transfer of intact acetate between histone
acetylation sites, by action of a histone deacetylase, ACSS2, and a histone
acetyltransferase. We show ACSS2 directly converts intact acetate released from
histones to acetyl-CoA, and this acetyl-CoA is utilized to acetylate the histone peptide.
2. We investigated intact acetate transfer in vivo using quiescence exit in S. cerevisiae
as a simple change-of-state model. Using stable isotope labeling with heavy acetate,
we show that intact heavy acetate can be transferred between histone lysine residues
during quiescence exit. We further validated our experimental procedures to show that
our washing step is sufficient to remove exogenous heavy acetate prior to refeeding.
Moreover, we also demonstrate an increase of intracellular heavy acetate during
quiescence exit, which is significantly reduced in the presence of HDAC inhibitors,
further supporting the transfer of heavy acetate.
3. We demonstrate that Acs2, the yeast homolog of ACSS2, is localized to facilitate
acetate transfer during quiescence exit: Acs2 is recruited to the genome during
quiescence exit, specifically at growth genes and at regions with the largest
transcriptional changes.
4. We observe striking differences in endogenous histone acetylation both globally and
locally during yeast quiescence exit. Therefore, we propose certain acetylation sites
could function as “reservoir” acetylation sites storing acetate during quiescence, while
other sites mainly function as “activating” acetylation sites that receive acetyl groups
to mediate gene activation during quiescence exit.

Taken together, these findings are important as the first (to our knowledge) to empirically
show direct transfer of intact acetate between histone acetylation sites, via coordination of
metabolic and epigenetic enzymes. This novel mechanism may drive expression of genes for
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growth and cell proliferation during changes in metabolic state. For an extended discussion of this
study, please refer to the discussion section of chapter 2 (pages 29-33).
In the third chapter of this dissertation, we applied proteomic and genomic approaches to
identify nuclear ACSS2 interactors during neuronal differentiation. To date, only a number of
nuclear ACSS2 interactors have been identified, such as TFEB in the context of glioblastoma cells
and HIF2a in hypoxic hepatocyte cells (Li et al. 2017; Xu et al. 2014). We sought to identify
candidate nuclear ACSS2 interactors important for neuronal differentiation. The following main
findings were concluded:
1. We performed a comprehensive study of ACSS2 interactors in CAD cell line and
ACSS2 WT/KO mouse models by performing IP-MS, using endogenous antibodies
against ACSS2. From this analysis, we identified NACC1 as a candidate ACSS2
interactor that overlapped in both datasets. We have validated this interaction via coimmunoprecipitations.
2. NACC1 and ACSS2 both increase localization to the nucleus during differentiation in
CAD cells. We performed subcellular fractionation coupled to proteomics analysis to
identify cytoplasmic and nuclear protein changes during differentiation, and we found
nuclear ACSS2 steadily increases during differentiation, while NACC1 levels increase
during the intermediate time points.
3. ChIP-seq analysis show overlap of ACSS2 and NACC1 peaks in differentiated CAD
cells. We observed a majority (174 out of 223) of ACSS2 peaks overlap with NACC1,
demonstrating that most of chromatin-bound ACSS2 is associated with NACC1. Gene
ontology analysis of ACSS2- and NACC1-bound regions include enrichment of
cytoplasmic and cell-cell adherens junction genes, which are important in
differentiation and formation of neuronal processes. Motif analysis of ACSS2 and
NACC1 peaks identified a significant enrichment for Phox2a binding motifs. We also
observed a positive correlation between ACSS2 and NACC1 binding at NACC1 peaks
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and at ACSS2 peaks. Taken together, these results highlight a novel association
between chromatin-bound ACSS2 and NACC1 in differentiated CAD cells.
4. In differentiated cells, ACSS2 and NACC1 is highly enriched at the promoter of Eif4g2
gene, consistent with increases in H3K27ac and mRNA expression. EIF4G2 is
important in translation of proteins that play critical roles in cell differentiation, such as
MAP3K3 and SOS1, which are upstream of ERK1/2 in MAPK pathway (Sugiyama et
al. 2017). This finding further supports our hypothesis that ACSS2 and NACC1 are
involved in regulating genes important for differentiation and formation of neuronal
processes, through its local production of acetyl-CoA for increased histone acetylation.

Overall, our results identify NACC1 as a novel ACSS2 interactor in the context of neuronal
differentiation. NACC1 and ACSS2 are co-localized at chromatin in differentiated CAD cells to
regulate subsets of genes, such as Eif4g2, which are important for differentiation. This interaction
may be crucial in recruiting ACSS2 to chromatin to provide local acetyl-CoA pools for increased
histone acetylation and gene activation. For an extended discussion of this study, please refer to
the discussion section of chapter 3 (pages 63-65).
In the fourth chapter of this dissertation, we focused our efforts in improving the current
middle-down workflow for analyzing combinatorial histone PTMs (Coradin, Mendoza et al. 2020).
Middle-down MS is used to analyze long polypeptides (~50 aa) that retain more information about
co-existing PTMs than bottom-up proteomics, and is far less technically challenging than top-down
proteomics (Lu et al. 2020). However, because of the high complexity of this method, i.e. special
chromatography with a different buffer system and relatively complex data processing steps, there
are very few chromatin biology studies utilizing this approach. Our study describes critical aspects
of middle-down proteomics for histone PTM analysis and provide a streamlined way to evaluate
performance. Our work revealed the following main findings:
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1. Addition of porous graphitic carbon (PGC) on top of the C18 disc during stage tipping
reduced sample loss during sample preparation, thereby increasing the number of
isoforms identified. This reflects the increased selectivity of PGC in retaining polar
solutes. The reduction in sample loss is critical, since middle-down MS typically
requires 50 µg of starting material (compared to ~ 20 µg or less for bottom-up).
2. Substitution of ethylenediammonium ion for ammonium ion in Buffer A results in better
reproducibility. Traditionally, Buffer A in middle-down chromatography includes
adjusting the pH with ammonium hydroxide; however, ethylenediammonium ion forms
more hydrated ion pairs with the acidic residues in histones (Alpert 2018), resulting in
better separation of H3 isoforms, ultimately increasing reproducibility of middle-down
analysis.

Overall, our study provides a simplified workflow to evaluate middle-down performance for
identification and quantification of histone PTMs, which is a useful resource for beginners. For an
extended discussion of this study, please refer to the discussion section of chapter 4 (pages 8284).
Beyond the work presented in chapters 2-4, I have also made significant contributions to
two particular studies utilizing MS-based approaches in interrogating epigenetic mechanisms. In
the first work, we performed a comprehensive identification and quantification of combinatorial
histone PTMs in the malaria parasite, Plasmodium falciparum, using middle-down MS (von Gruning
et al. 2022). In the second study, we analyzed histone PTMs from the dorsal hippocampus of mice
that are either WT or KO for ACSS2 that have undergone fear conditioning using bottom-up MS
and observed dynamic histone acetylation changes (Alexander et al. PNAS In revision).
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5.2 Future directions
The studies presented in chapters 2 and 3 have greatly increased our knowledge on the
role of nuclear ACSS2 in maintaining histone acetylation, specifically in mediating a local transfer
of acetate between histone residues. Furthermore, our studies revealed a novel mechanism of
ACSS2 recruitment to chromatin in the context of neuronal differentiation through its interaction
with NACC1. However, many questions remain unanswered. In the following sections I will describe
open questions and possible follow-up experiments.
5.2.1 Dependence on Acs2 for acetate transfer during quiescence exit
In chapter 2, we show that intact acetate can be directly transferred between histone acetyllysine residues using in vitro and in vivo approaches. From our in vitro assays, we demonstrate
that ACSS2 is important for the acetyl group transfer, as we observed incorporation of acetyl groups
at a novel site at K18 only when all essential enzymes (including ACSS2) is present in the reaction
mixture. However, recapitulating these findings in the yeast quiescence model would contribute
significantly to our study. To interrogate this in the yeast model, it would be interesting to perform
the same yeast quiescence exit experiments, this time in parallel with a temperature sensitive strain
of Acs2 (Acs2-Ts). Acs2 is an essential enzyme in yeast, so we would need alternate ways in
manipulating enzyme levels and activity (Van den Berg and Steensma 1995). Previous studies
have utilized Acs2-Ts, wherein they used the Salmonella Acs2 fused to the yeast Acs2 promoter,
since prokaryotic Acs proteins lack the nuclear localization signal present in yeast Acs2 (Takahashi
et al. 2006). Then, fusing Acs2-Ts with a NLS or NES should direct its localization outside or inside
the nucleus. We would then perform the same quiescence experiments in the presence of the NLSAcs2-Ts or NES-Acs2-Ts and use MS to quantify heavy acetylation incorporated at histone
residues during quiescence exit.
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5.2.2 Role of specific histone lysine residues as reservoir or activating histone acetylation
sites
From our study in chapter 2, using MS and genomics approaches we observed that there
are different patterns of acetylation changes during quiescence exit, wherein some sites are more
highly induced than others. We then hypothesized that specific lysine residues (such as H3K14,
K18, K23, and H4K16) can act as reservoir acetylation sites that serve as local stores for acetyl
groups. Then, acetate is released and transferred to activating acetylation sites, particularly at
H3K9 and K27, during quiescence exit and transcriptional demand increases. We also show that
heavy acetate is released from histones during quiescence exit, further supporting that heavy
acetate is incorporated at histones during quiescence state. Additional studies to interrogate the
role of reservoir vs activating acetylation sites would aid in our knowledge on studying the reservoir
function of histones. To test this, we would mutate each of this lysine site to alanine and perform
the same quiescence exit experiments to determine whether heavy acetate would be transferred
to activating acetylation sites in the presence of the alanine mutant. We would prepare strains
bearing K to A mutations in each of these sites: H3K9, K14, K18, K23, K27, and H4K16. Mutations
at these sites do not affect viability as demonstrated by previous yeast studies (Nakanishi et al.
2008). Then we would determine which residues preferentially incorporate heavy acetyl groups
during quiescence and quiescence exit in the presence of the alanine substitutions. This
experiment will further provide information on the reservoir function of histones and interrogate the
role of specific acetyl-lysine sites as reservoir or activating.
5.2.3 Mechanisms of acetyl transfer in mammalian change-of-state models
Although we demonstrate this acetyl-group transfer in yeast quiescence exit as a changeof-state model, future work will address these mechanisms in mammalian change-of-state models
such as neuronal differentiation or in disease models such as cancer, wherein some tumors are
more preferentially dependent on acetate for growth (Comerford et al. 2014). Kinetic flux
experiments have shown that while some exogenous acetate can be incorporated for histone
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acetylation, most exogenous acetate is utilized in the cytosol for lipid synthesis (Bulusu et al. 2017;
Sivanand, Viney, and Wellen 2018). These findings suggest that maintenance of nuclear acetylCoA relies on a locally produced acetate pool, likely from histone deacetylation at reservoir
acetylation sites. It remains unclear whether a local transfer of acetyl groups could be detected
when these cells undergo metabolic stress, which could then drive the expression of genes
essential for survival. Moreover, our studies in chapter 3 together with previous work in the lab
highlight the role of nuclear ACSS2 in neuronal context, particularly in consolidation of long-term
and fear memories as well as neural plasticity during addiction (see 5.2.7). Since histone
acetylation is important for transcriptional activation of key genes in these models, it is possible that
nuclear ACSS2 is involved in regulating local acetyl-CoA pools through mediating a local transfer
of acetate from reservoir acetylation sites.
With current advances in chemical biology techniques to study epigenetic mechanisms,
chromatin could be site-specifically labeled in live cells to track acetyl transfer using split inteins
(David and Muir 2017; David et al. 2015). Coupled to mass spectrometry, this technique would
allow us to detect specific residues that incorporate the labeled acetyl groups upon changes of
state. Moreover, novel MS-based approaches have been developed for metabolite quantitation in
subcellular compartments (Trefely et al. 2022). Combined with split intein technology, we can utilize
this technique to quantify relative abundances of nuclear vs cytoplasmic heavy acetyl-CoA that has
been released from histone acetyl-lysines.
5.2.4 Direct interaction between ACSS2 and NACC1 in the nucleus
One of our major findings in chapter 3 identifies NACC1 as a novel ACSS2 interactor in
the nucleus of CAD cells and in mouse dHPC. However, it is unclear whether ACSS2 and NACC1
can directly bind with each other. To test this, we need to prepare purified ACSS2 and NACC1 for
in vitro pulldown assays. Probing for direct interaction between ACSS2 and NACC1 will shed light
in the mechanisms of nuclear ACSS2 in the context of neuronal differentiation. Specifically, this will
also inform whether nuclear ACSS2 binds chromatin through direct interaction with NACC1.
95

5.2.5 Functional role of NACC1 on ACSS2 recruitment to chromatin
Our ChIP-seq results in chapter 3 indicate that ACSS2 and NACC1 co-localize at specific
regions in the chromatin. Additional studies to further interrogate the mechanism of ACSS2 and
NACC1 will be important in understanding its nuclear role in neuronal differentiation. We
hypothesize that NACC1 aids in recruiting ACSS2 to chromatin, as majority of ACSS2 ChIP-seq
peaks in differentiated CAD cells are also bound with NACC1. Gene ontology analysis of ACSS2,
NACC1, and H3K27ac peaks revealed significant enrichment near genes of cytoskeleton, cell-cell
adherens junction, and membrane, which is consistent with morphological changes observed in
differentiated CAD cells. These findings further support our hypothesis that ACSS2 and NACC1
are recruited to specific subsets of genes that are important for neuronal differentiation and
formation of processes. It would be interesting to test whether knockdown of either ACSS2 or
NACC1 will affect the differentiation process in CAD cells by examining morphological changes
and measuring levels of neuronal markers during serum deprivation. Moreover, performing ChIPseq of ACSS2 or NACC1 in CAD cells depleted with NACC1 or ACSS2, respectively, will assess
whether this interaction alone is necessary for chromatin recruitment. We hypothesize that nuclear
ACSS2 would need NACC1 for its association to chromatin; however, NACC1 might have other
roles in chromatin independent of ACSS2.
5.2.6 Genome-wide localization of ACSS2 and NACC1 during the intermediate time points of
differentiation.
While both ACSS2 and NACC1 are nuclear in differentiated CAD cells, our findings showed
that NACC1 levels in the nucleus increases during the intermediate time points of differentiation,
specifically at days 2 and 3. During these time points, CAD cells are in the process of differentiating,
wherein chromatin landscape is very dynamic. Our histone PTM analysis showed that global
acetylation decreases during differentiation and methylation increases, since the CAD cells are
transitioning to a terminal neuronal-like state. We predict that nuclear ACSS2 and NACC1 could
be playing critical roles during these time points. This can be tested by performing ChIP-seq for
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ACSS2, NACC1, and H3K27ac during day 3 of differentiation, and also performing RNA-seq to
assess gene expression. Comparing these results with the genomics data from undifferentiated
and day 5 differentiated cells, these experiments have the ability to provide additional information
on ACSS2 and NACC1 localization during differentiation.
5.2.7 Mechanisms of nuclear ACSS2 and NACC1 in in vivo mouse models and learning and
memory formation
Since the genomics studies we presented in chapter 3 were performed in CAD cells, future
work to interrogate the mechanisms of nuclear ACSS2 and NACC1 involve performing the same
genomics analysis in in vivo mouse models. It would be interesting to assess NACC1 and ACSS2
recruitment in dHPC of mice either WT or KO for ACSS2. ACSS2 is expressed throughout the
hippocampus, and thus could mediate histone acetylation to upregulate gene expression during
memory consolidation (Mews et al. 2017). To test whether ACSS2 and NACC1 are involved in
dynamic gene upregulation during memory formation, we would perform RNA-seq and ChIP-seq
of ACSS2 and NACC1 on dHPC of mice that have undergone spatial object training. We predict
that ACSS2 and NACC1 would also co-localize at specific genomic regions after training, as they
would be involved in upregulating genes important for memory and learning. Similarly, it would also
be interesting to deplete ACSS2 or NACC1 in dHPC of mice undergoing spatial object training and
perform RNA-seq to determine gene expression changes.
Based from our findings in chapter 3 and previous work in the lab, a common feature of
nuclear ACSS2 is its role in neural plasticity during learning and memory. ACSS2 is involved in
neuronal gene expression and expression of memory-related gene during establishment of longterm memories (Mews et al. 2017) and fear memories (Alexander et al. PNAS In revision).
Moreover, ACSS2 has also been shown to affect alcohol-related learning and encoding
environmental cues that drive craving after abstinence (Mews et al. 2019). Taken together, these
findings highlight ACSS2 as a metabolic enzyme critical during neuroplasticity, as ACSS2 is
essential for neuronal histone acetylation and activation of memory-related neuroplasticity genes.
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Our studies in chapter 3 further supports this model, as NACC1 is first overexpressed in the nucleus
accumbens of rats after self-administering cocaine (Cha et al. 1997; Mackler et al. 2000). NACC1
has been found to interact with HDAC3 and HDAC4 (Korutla, Wang, and Mackler 2005),
highlighting its role in histone acetylation and regulating cocaine-induced changes in neural
plasticity. Chronic cocaine self-administration leads to changes in gene expression (i.e. Bdnf, Fos,
Egr1) through histone acetylation; thus, it is possible that ACSS2 and NACC1 are involved in
regulating nuclear acetyl-CoA pools at these key genomic loci (Hamilton and Nestler 2019). Future
studies would investigate this interaction in animal models of addiction, such as drug selfadministration, to further understand their mechanisms and provide potential therapeutic targets
for neuropsychiatric disorders.
5.2.8 Developments in middle-down MS for histone PTM analysis
The fourth chapter of this dissertation focused on optimizing the current middle-down
workflow for histone PTM analysis. Our findings revealed improvements in sample retention and
chromatographic separation of histone tails; however, there are still improvements that can be
made to improve middle-down analysis. Our study uses WCX-HILIC chromatography to separate
histone tails, but most MS laboratories do not readily have this setup, since reversed-phase
chromatography is more robust and is routinely used for bottom-up proteomics analysis that have
C18 columns coupled with MS. Recent advances in middle-down MS have begun to employ
reversed-phase chromatography and help it make more suitable for separating hydrophilic 50 aa
long histone peptides. One study described a chemical derivatization strategy using Nhydroxysuccinamide propionate ester to derivatize histone tails and separate using reversedphase, and they identified over 200 combinatorial histone PTMs from lymphoma cells (Liao et al.
2017). A study from our lab used porous graphitic carbon, which was also used in our study to
increase sample retention during desalting, as a stationary phase for reversed-phase
chromatography, wherein they achieved simultaneous bottom-up and middle-down histone PTM
analysis from one injection (Janssen et al. 2019). From this study, even though the number of
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identifications is lower compared to WCX-HILIC chromatography, the interplay score of
modifications is in high agreement, demonstrating that a middle-down type of analysis is still
achieved despite the lower quantity of identified proteoforms. Overall, these studies will allow more
MS laboratories to employ middle-down analysis in studying combinatorial histone PTMs to
interrogate PTM crosstalk in various biological systems.

99

BIBLIOGRAPHY
Aguilar-Arnal, L., S. Ranjit, C. Stringari, R. Orozco-Solis, E. Gratton, and P. Sassone-Corsi. 2016.
'Spatial dynamics of SIRT1 and the subnuclear distribution of NADH species',
Proceedings of the National Academy of Sciences of the United States of America, 113:
12715-20.
Allis, C. D., and T. Jenuwein. 2016. 'The molecular hallmarks of epigenetic control', Nature
Reviews: Genetics, 17: 487-500.
Alpert, A. J. 2018. 'Effect of salts on retention in hydrophilic interaction chromatography', Journal
of Chromatography A, 1538: 45-53.
Bakker, B. M., F. I. Mensonides, B. Teusink, P. van Hoek, P. A. Michels, and H. V. Westerhoff.
2000. 'Compartmentation protects trypanosomes from the dangerous design of
glycolysis', Proceedings of the National Academy of Sciences of the United States of
America, 97: 2087-92.
Bannister, A. J., and T. Kouzarides. 2011. 'Regulation of chromatin by histone modifications', Cell
Research, 21: 381-95.
Bapiro, T. E., F. M. Richards, and D. I. Jodrell. 2016. 'Understanding the Complexity of Porous
Graphitic Carbon (PGC) Chromatography: Modulation of Mobile-Stationary Phase
Interactions Overcomes Loss of Retention and Reduces Variability', Analytical Chemistry,
88: 6190-4.
Beaulieu, A. M., and D. B. Sant'Angelo. 2011. 'The BTB-ZF family of transcription factors: key
regulators of lineage commitment and effector function development in the immune
system', Journal of Immunology, 187: 2841-7.
Berger, S. L., T. Kouzarides, R. Shiekhattar, and A. Shilatifard. 2009. 'An operational definition of
epigenetics', Genes Dev, 23: 781-3.
Bitterman, K. J., R. M. Anderson, H. Y. Cohen, M. Latorre-Esteves, and D. A. Sinclair. 2002.
'Inhibition of silencing and accelerated aging by nicotinamide, a putative negative
regulator of yeast sir2 and human SIRT1', Journal of Biological Chemistry, 277: 45099107.
Black, J. C., A. Mosley, T. Kitada, M. Washburn, and M. Carey. 2008. 'The SIRT2 deacetylase
regulates autoacetylation of p300', Molecular Cell, 32: 449-55.
Boija, A., I. A. Klein, B. R. Sabari, A. Dall'Agnese, E. L. Coffey, A. V. Zamudio, C. H. Li, K.
Shrinivas, J. C. Manteiga, N. M. Hannett, B. J. Abraham, L. K. Afeyan, Y. E. Guo, J. K.
Rimel, C. B. Fant, J. Schuijers, T. I. Lee, D. J. Taatjes, and R. A. Young. 2018.
'Transcription Factors Activate Genes through the Phase-Separation Capacity of Their
Activation Domains', Cell, 175: 1842-55 e16.
Boon, R., G. G. Silveira, and R. Mostoslavsky. 2020. 'Nuclear metabolism and the regulation of
the epigenome', Nat Metab.
Bose, S., V. Ramesh, and J. W. Locasale. 2019. 'Acetate Metabolism in Physiology, Cancer, and
Beyond', Trends in Cell Biology, 29: 695-703.
Boukouris, A. E., S. D. Zervopoulos, and E. D. Michelakis. 2016. 'Metabolic Enzymes
Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription', Trends in
Biochemical Sciences, 41: 712-30.
Bulusu, V., S. Tumanov, E. Michalopoulou, N. J. van den Broek, G. MacKay, C. Nixon, S.
Dhayade, Z. T. Schug, J. Vande Voorde, K. Blyth, E. Gottlieb, A. Vazquez, and J. J.
Kamphorst. 2017. 'Acetate Recapturing by Nuclear Acetyl-CoA Synthetase 2 Prevents
Loss of Histone Acetylation during Oxygen and Serum Limitation', Cell Rep, 18: 647-58.
Cha, X. Y., R. C. Pierce, P. W. Kalivas, and S. A. Mackler. 1997. 'NAC-1, a rat brain mRNA, is
increased in the nucleus accumbens three weeks after chronic cocaine selfadministration', Journal of Neuroscience, 17: 6864-71.
Chambers, M. C., B. Maclean, R. Burke, D. Amodei, D. L. Ruderman, S. Neumann, L. Gatto, B.
Fischer, B. Pratt, J. Egertson, K. Hoff, D. Kessner, N. Tasman, N. Shulman, B. Frewen,
100

T. A. Baker, M. Y. Brusniak, C. Paulse, D. Creasy, L. Flashner, K. Kani, C. Moulding, S.
L. Seymour, L. M. Nuwaysir, B. Lefebvre, F. Kuhlmann, J. Roark, P. Rainer, S. Detlev, T.
Hemenway, A. Huhmer, J. Langridge, B. Connolly, T. Chadick, K. Holly, J. Eckels, E. W.
Deutsch, R. L. Moritz, J. E. Katz, D. B. Agus, M. MacCoss, D. L. Tabb, and P. Mallick.
2012. 'A cross-platform toolkit for mass spectrometry and proteomics', Nature
Biotechnology, 30: 918-20.
Cohen, R. D., Y. Liu, and X. Gong. 2012. 'Analysis of volatile bases by high performance liquid
chromatography with aerosol-based detection', Journal of Chromatography A, 1229: 1729.
Comerford, S. A., Z. Huang, X. Du, Y. Wang, L. Cai, A. K. Witkiewicz, H. Walters, M. N. Tantawy,
A. Fu, H. C. Manning, J. D. Horton, R. E. Hammer, S. L. McKnight, and B. P. Tu. 2014.
'Acetate dependence of tumors', Cell, 159: 1591-602.
Connelly, K. E., V. Hedrick, T. J. Paschoal Sobreira, E. C. Dykhuizen, and U. K. Aryal. 2018.
'Analysis of Human Nuclear Protein Complexes by Quantitative Mass Spectrometry
Profiling', Proteomics, 18: e1700427.
Coppola, E., F. d'Autreaux, F. M. Rijli, and J. F. Brunet. 2010. 'Ongoing roles of Phox2
homeodomain transcription factors during neuronal differentiation', Development, 137:
4211-20.
Coppola, E., A. Pattyn, S. C. Guthrie, C. Goridis, and M. Studer. 2005. 'Reciprocal gene
replacements reveal unique functions for Phox2 genes during neural differentiation',
EMBO Journal, 24: 4392-403.
Coradin, M., M. R. Mendoza, S. Sidoli, A. J. Alpert, C. Lu, and B. A. Garcia. 2020. 'Bullet points to
evaluate the performance of the middle-down proteomics workflow for histone
modification analysis', Methods, 184: 86-92.
Cristobal, A., F. Marino, H. Post, H. W. van den Toorn, S. Mohammed, and A. J. Heck. 2017.
'Toward an Optimized Workflow for Middle-Down Proteomics', Analytical Chemistry, 89:
3318-25.
Dang, X., A. Singh, B. D. Spetman, K. D. Nolan, J. S. Isaacs, J. H. Dennis, S. Dalton, A. G.
Marshall, and N. L. Young. 2016. 'Label-Free Relative Quantitation of Isobaric and
Isomeric Human Histone H2A and H2B Variants by Fourier Transform Ion Cyclotron
Resonance Top-Down MS/MS', Journal of Proteome Research, 15: 3196-203.
Darwanto, A., M. P. Curtis, M. Schrag, W. Kirsch, P. Liu, G. Xu, J. W. Neidigh, and K. Zhang.
2010. 'A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79
methylation', Journal of Biological Chemistry, 285: 21868-76.
David, Y., and T. W. Muir. 2017. 'Emerging Chemistry Strategies for Engineering Native
Chromatin', Journal of the American Chemical Society, 139: 9090-96.
David, Y., M. Vila-Perello, S. Verma, and T. W. Muir. 2015. 'Chemical tagging and customizing of
cellular chromatin states using ultrafast trans-splicing inteins', Nature Chemistry, 7: 394402.
Dexter, J. P., P. S. Ward, T. Dasgupta, A. M. Hosios, J. Gunawardena, and M. G. Vander Heiden.
2018. 'Lack of evidence for substrate channeling or flux between wildtype and mutant
isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate', Journal of
Biological Chemistry, 293: 20051-61.
Distler, U., M. J. Schmeisser, A. Pelosi, D. Reim, J. Kuharev, R. Weiczner, J. Baumgart, T. M.
Boeckers, R. Nitsch, J. Vogt, and S. Tenzer. 2014. 'In-depth protein profiling of the
postsynaptic density from mouse hippocampus using data-independent acquisition
proteomics', Proteomics, 14: 2607-13.
Egervari, G., K. M. Glastad, and S. L. Berger. 2020. 'Food for thought', Science, 370: 660-62.
Etchegaray, J. P., and R. Mostoslavsky. 2016. 'Interplay between Metabolism and Epigenetics: A
Nuclear Adaptation to Environmental Changes', Molecular Cell, 62: 695-711.
Figlia, G., P. Willnow, and A. A. Teleman. 2020. 'Metabolites Regulate Cell Signaling and Growth
via Covalent Modification of Proteins', Developmental Cell, 54: 156-70.
101

Friis, R. M., B. P. Wu, S. N. Reinke, D. J. Hockman, B. D. Sykes, and M. C. Schultz. 2009. 'A
glycolytic burst drives glucose induction of global histone acetylation by picNuA4 and
SAGA', Nucleic Acids Research, 37: 3969-80.
Goldberg, A. D., C. D. Allis, and E. Bernstein. 2007. 'Epigenetics: a landscape takes shape', Cell,
128: 635-8.
Good, D. M., M. Wirtala, G. C. McAlister, and J. J. Coon. 2007. 'Performance characteristics of
electron transfer dissociation mass spectrometry', Mol Cell Proteomics, 6: 1942-51.
Greer, S. M., and J. S. Brodbelt. 2018. 'Top-Down Characterization of Heavily Modified Histones
Using 193 nm Ultraviolet Photodissociation Mass Spectrometry', Journal of Proteome
Research, 17: 1138-45.
Greer, S. M., S. Sidoli, M. Coradin, M. Schack Jespersen, V. Schwammle, O. N. Jensen, B. A.
Garcia, and J. S. Brodbelt. 2018. 'Extensive Characterization of Heavily Modified Histone
Tails by 193 nm Ultraviolet Photodissociation Mass Spectrometry via a Middle-Down
Strategy', Analytical Chemistry, 90: 10425-33.
Haberland, M., R. L. Montgomery, and E. N. Olson. 2009. 'The many roles of histone
deacetylases in development and physiology: implications for disease and therapy',
Nature Reviews: Genetics, 10: 32-42.
Hamilton, P. J., and E. J. Nestler. 2019. 'Epigenetics and addiction', Current Opinion in
Neurobiology, 59: 128-36.
Handy, D. E., R. Castro, and J. Loscalzo. 2011. 'Epigenetic modifications: basic mechanisms and
role in cardiovascular disease', Circulation, 123: 2145-56.
Hosios, A. M., and M. G. Vander Heiden. 2014. 'Acetate metabolism in cancer cells', Cancer
Metab, 2: 27.
Huang, M., X. Xiao, G. Ji, and Q. Wu. 2022. 'Histone modifications in neurodifferentiation of
embryonic stem cells', Heliyon, 8: e08664.
Hunt, M. C., M. I. Siponen, and S. E. Alexson. 2012. 'The emerging role of acyl-CoA
thioesterases and acyltransferases in regulating peroxisomal lipid metabolism', Biochim
Biophys Acta, 1822: 1397-410.
Janssen, K. A., M. Coradin, C. Lu, S. Sidoli, and B. A. Garcia. 2019. 'Quantitation of Single and
Combinatorial Histone Modifications by Integrated Chromatography of Bottom-up
Peptides and Middle-down Polypeptide Tails', Journal of the American Society for Mass
Spectrometry, 30: 2449-59.
Janssen, K. A., S. Sidoli, and B. A. Garcia. 2017. 'Recent Achievements in Characterizing the
Histone Code and Approaches to Integrating Epigenomics and Systems Biology',
Methods in Enzymology, 586: 359-78.
Jensen, P. H., S. Mysling, P. Hojrup, and O. N. Jensen. 2013. 'Glycopeptide enrichment for
MALDI-TOF mass spectrometry analysis by hydrophilic interaction liquid chromatography
solid phase extraction (HILIC SPE)', Methods in Molecular Biology, 951: 131-44.
Johnson, C. A., D. A. White, J. S. Lavender, L. P. O'Neill, and B. M. Turner. 2002. 'Human class I
histone deacetylase complexes show enhanced catalytic activity in the presence of ATP
and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70', Journal of
Biological Chemistry, 277: 9590-7.
Karch, K. R., J. E. Denizio, B. E. Black, and B. A. Garcia. 2013. 'Identification and interrogation of
combinatorial histone modifications', Front Genet, 4: 264.
Karch, K. R., S. Sidoli, and B. A. Garcia. 2016. 'Identification and Quantification of Histone PTMs
Using High-Resolution Mass Spectrometry', Methods in Enzymology, 574: 3-29.
Karch, K. R., B. M. Zee, and B. A. Garcia. 2014. 'High resolution is not a strict requirement for
characterization and quantification of histone post-translational modifications', Journal of
Proteome Research, 13: 6152-9.
Korutla, L., H. A. th Furlong, and S. A. Mackler. 2014. 'NAC1, A POZ/BTB protein interacts with
Parkin and may contribute to Parkinson's disease', Neuroscience, 257: 86-95.
102

Korutla, L., P. J. Wang, and S. A. Mackler. 2005. 'The POZ/BTB protein NAC1 interacts with two
different histone deacetylases in neuronal-like cultures', Journal of Neurochemistry, 94:
786-93.
Kouzarides, T. 2007. 'Chromatin modifications and their function', Cell, 128: 693-705.
Li, X., G. Egervari, Y. Wang, S. L. Berger, and Z. Lu. 2018. 'Regulation of chromatin and gene
expression by metabolic enzymes and metabolites', Nature Reviews: Molecular Cell
Biology, 19: 563-78.
Li, X., X. Qian, and Z. Lu. 2017. 'Local histone acetylation by ACSS2 promotes gene transcription
for lysosomal biogenesis and autophagy', Autophagy, 13: 1790-91.
Li, X., W. Yu, X. Qian, Y. Xia, Y. Zheng, J. H. Lee, W. Li, J. Lyu, G. Rao, X. Zhang, C. N. Qian, S.
G. Rozen, T. Jiang, and Z. Lu. 2017. 'Nucleus-Translocated ACSS2 Promotes Gene
Transcription for Lysosomal Biogenesis and Autophagy', Molecular Cell, 66: 684-97 e9.
Liao, R., D. Zheng, A. Nie, S. Zhou, H. Deng, Y. Gao, P. Yang, Y. Yu, L. Tan, W. Qi, J. Wu, E. Li,
and W. Yi. 2017. 'Sensitive and Precise Characterization of Combinatorial Histone
Modifications by Selective Derivatization Coupled with RPLC-EThcD-MS/MS', Journal of
Proteome Research, 16: 780-87.
Lieber, C. S. 1997. 'Ethanol metabolism, cirrhosis and alcoholism', Clinica Chimica Acta, 257: 5984.
Lin, S., and B. A. Garcia. 2012. 'Examining histone posttranslational modification patterns by
high-resolution mass spectrometry', Methods in Enzymology, 512: 3-28.
Lin-Shiao, E., Y. Lan, M. Coradin, A. Anderson, G. Donahue, C. L. Simpson, P. Sen, R. Saffie, L.
Busino, B. A. Garcia, S. L. Berger, and B. C. Capell. 2018. 'KMT2D regulates p63 target
enhancers to coordinate epithelial homeostasis', Genes Dev, 32: 181-93.
Louis, P., G. L. Hold, and H. J. Flint. 2014. 'The gut microbiota, bacterial metabolites and
colorectal cancer', Nature Reviews: Microbiology, 12: 661-72.
Lu, C., M. Coradin, E. G. Porter, and B. A. Garcia. 2020. 'Accelerating the Field of Epigenetic
Histone Modification Through Mass Spectrometry-Based Approaches', Mol Cell
Proteomics, 20: 100006.
Luger, K. 2001. 'Nucleosomes: Structure and Function'.
Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent, and T. J. Richmond. 1997. 'Crystal
structure of the nucleosome core particle at 2.8 A resolution', Nature, 389: 251-60.
Lunn, D. B., Y. J. Yun, and J. W. Jorgenson. 2017. 'Retention and effective diffusion of model
metabolites on porous graphitic carbon', Journal of Chromatography A, 1530: 112-19.
Luo, J., F. Su, D. Chen, A. Shiloh, and W. Gu. 2000. 'Deacetylation of p53 modulates its effect on
cell growth and apoptosis', Nature, 408: 377-81.
Luong, A., V. C. Hannah, M. S. Brown, and J. L. Goldstein. 2000. 'Molecular characterization of
human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding
proteins', Journal of Biological Chemistry, 275: 26458-66.
Mackler, S. A., L. Korutla, X. Y. Cha, M. J. Koebbe, K. M. Fournier, M. S. Bowers, and P. W.
Kalivas. 2000. 'NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced
sensitization in the rat', Journal of Neuroscience, 20: 6210-17.
Marczak, L., P. Znajdek-Awizen, and W. Bylka. 2016. 'The Use of Mass Spectrometric
Techniques to Differentiate Isobaric and Isomeric Flavonoid Conjugates from Axyris
amaranthoides', Molecules, 21.
Marmorstein, R., and M. M. Zhou. 2014. 'Writers and readers of histone acetylation: structure,
mechanism, and inhibition', Cold Spring Harbor Perspectives in Biology, 6: a018762.
Martin, B. J. E., J. Brind'Amour, A. Kuzmin, K. N. Jensen, Z. C. Liu, M. Lorincz, and L. J. Howe.
2021. 'Transcription shapes genome-wide histone acetylation patterns', Nat Commun, 12:
210.
Mendoza, M., G. Egervari, S. Sidoli, G. Donahue, D. C. Alexander, P. Sen, B. A. Garcia, and S.
L. Berger. 2022. 'Enzymatic transfer of acetate on histones from lysine reservoir sites to
lysine activating sites', Sci Adv, 8: eabj5688.
103

Mews, P., G. Donahue, A. M. Drake, V. Luczak, T. Abel, and S. L. Berger. 2017. 'Acetyl-CoA
synthetase regulates histone acetylation and hippocampal memory', Nature, 546: 381-86.
Mews, P., G. Egervari, R. Nativio, S. Sidoli, G. Donahue, S. I. Lombroso, D. C. Alexander, S. L.
Riesche, E. A. Heller, E. J. Nestler, B. A. Garcia, and S. L. Berger. 2019. 'Alcohol
metabolism contributes to brain histone acetylation', Nature, 574: 717-21.
Mews, P., B. M. Zee, S. Liu, G. Donahue, B. A. Garcia, and S. L. Berger. 2014. 'Histone
methylation has dynamics distinct from those of histone acetylation in cell cycle reentry
from quiescence', Mol Cell Biol, 34: 3968-80.
Molden, R. C., and B. A. Garcia. 2014. 'Middle-Down and Top-Down Mass Spectrometric
Analysis of Co-occurring Histone Modifications', Curr Protoc Protein Sci, 77: 23 7 1-23 7
28.
Moradian, A., A. Kalli, M. J. Sweredoski, and S. Hess. 2014. 'The top-down, middle-down, and
bottom-up mass spectrometry approaches for characterization of histone variants and
their post-translational modifications', Proteomics, 14: 489-97.
Nakanishi, S., B. W. Sanderson, K. M. Delventhal, W. D. Bradford, K. Staehling-Hampton, and A.
Shilatifard. 2008. 'A comprehensive library of histone mutants identifies nucleosomal
residues required for H3K4 methylation', Nature Structural & Molecular Biology, 15: 8818.
Narlikar, Geeta J. 2020. 'Phase-separation in chromatin organization', Journal of Biosciences, 45.
Nativio, R., Y. Lan, G. Donahue, S. Sidoli, A. Berson, A. R. Srinivasan, O. Shcherbakova, A.
Amlie-Wolf, J. Nie, X. Cui, C. He, L. S. Wang, B. A. Garcia, J. Q. Trojanowski, N. M.
Bonini, and S. L. Berger. 2020. 'An integrated multi-omics approach identifies epigenetic
alterations associated with Alzheimer's disease', Nature Genetics, 52: 1024-35.
Onder, O., S. Sidoli, M. Carroll, and B. A. Garcia. 2015. 'Progress in epigenetic histone
modification analysis by mass spectrometry for clinical investigations', Expert Rev
Proteomics, 12: 499-517.
Paauw, N. D., A. T. Lely, J. A. Joles, A. Franx, P. G. Nikkels, M. Mokry, and B. B. van Rijn. 2018.
'H3K27 acetylation and gene expression analysis reveals differences in placental
chromatin activity in fetal growth restriction', Clinical Epigenetics, 10: 85.
Pesavento, J. J., C. A. Mizzen, and N. L. Kelleher. 2006. 'Quantitative analysis of modified
proteins and their positional isomers by tandem mass spectrometry: Human histone H4',
Analytical Chemistry, 78: 4271-80.
Pietrocola, F., L. Galluzzi, J. M. Bravo-San Pedro, F. Madeo, and G. Kroemer. 2015. 'Acetyl
coenzyme A: a central metabolite and second messenger', Cell Metabolism, 21: 805-21.
Pino, L. K., S. C. Just, M. J. MacCoss, and B. C. Searle. 2020. 'Acquiring and Analyzing Data
Independent Acquisition Proteomics Experiments without Spectrum Libraries', Mol Cell
Proteomics, 19: 1088-103.
Plazas-Mayorca, M. D., B. M. Zee, N. L. Young, I. M. Fingerman, G. LeRoy, S. D. Briggs, and B.
A. Garcia. 2009. 'One-pot shotgun quantitative mass spectrometry characterization of
histones', Journal of Proteome Research, 8: 5367-74.
Podobinska, M., I. Szablowska-Gadomska, J. Augustyniak, I. Sandvig, A. Sandvig, and L.
Buzanska. 2017. 'Epigenetic Modulation of Stem Cells in Neurodevelopment: The Role of
Methylation and Acetylation', Frontiers in Cellular Neuroscience, 11: 23.
Qi, Yanping, James K. T. Wang, Michael McMillian, and Dona M. Chikaraishi. 1997.
'Characterization of a CNS Cell Line, CAD, in which Morphological Differentiation Is
Initiated by Serum Deprivation', The Journal of Neuroscience, 17: 1217-25.
Sardiello, M., M. Palmieri, A. di Ronza, D. L. Medina, M. Valenza, V. A. Gennarino, C. Di Malta,
F. Donaudy, V. Embrione, R. S. Polishchuk, S. Banfi, G. Parenti, E. Cattaneo, and A.
Ballabio. 2009. 'A gene network regulating lysosomal biogenesis and function', Science,
325: 473-7.
Schug, Z. T., J. Vande Voorde, and E. Gottlieb. 2016. 'The metabolic fate of acetate in cancer',
Nature Reviews: Cancer, 16: 708-17.
104

Schwammle, V., C. M. Aspalter, S. Sidoli, and O. N. Jensen. 2014. 'Large scale analysis of coexisting post-translational modifications in histone tails reveals global fine structure of
cross-talk', Mol Cell Proteomics, 13: 1855-65.
Schwammle, V., S. Sidoli, C. Ruminowicz, X. Wu, C. F. Lee, K. Helin, and O. N. Jensen. 2016.
'Systems level analysis of histone H3 post-translational modifications reveals features of
PTM crosstalk in chromatin regulation', Mol Cell Proteomics.
Searle, B. C., L. K. Pino, J. D. Egertson, Y. S. Ting, R. T. Lawrence, B. X. MacLean, J. Villen, and
M. J. MacCoss. 2018. 'Chromatogram libraries improve peptide detection and
quantification by data independent acquisition mass spectrometry', Nat Commun, 9:
5128.
Seto, E., and M. Yoshida. 2014. 'Erasers of histone acetylation: the histone deacetylase
enzymes', Cold Spring Harbor Perspectives in Biology, 6: a018713.
Shannon, P., A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B.
Schwikowski, and T. Ideker. 2003. 'Cytoscape: a software environment for integrated
models of biomolecular interaction networks', Genome Research, 13: 2498-504.
Shatsky, I. N., I. M. Terenin, V. V. Smirnova, and D. E. Andreev. 2018. 'Cap-Independent
Translation: What's in a Name?', Trends in Biochemical Sciences, 43: 882-95.
Sidoli, S., N. V. Bhanu, K. R. Karch, X. Wang, and B. A. Garcia. 2016. 'Complete Workflow for
Analysis of Histone Post-translational Modifications Using Bottom-up Mass Spectrometry:
From Histone Extraction to Data Analysis', J Vis Exp.
Sidoli, S., and B. A. Garcia. 2017a. 'Characterization of Individual Histone Posttranslational
Modifications and Their Combinatorial Patterns by Mass Spectrometry-Based Proteomics
Strategies', Methods in Molecular Biology, 1528: 121-48.
———. 2017b. 'Middle-down proteomics: a still unexploited resource for chromatin biology',
Expert Rev Proteomics, 14: 617-26.
Sidoli, S., Y. Kori, M. Lopes, Z. F. Yuan, H. J. Kim, K. Kulej, K. A. Janssen, L. M. Agosto, Jpcd
Cunha, A. J. Andrews, and B. A. Garcia. 2019. 'One minute analysis of 200 histone
posttranslational modifications by direct injection mass spectrometry', Genome Research,
29: 978-87.
Sidoli, S., S. Lin, K. R. Karch, and B. A. Garcia. 2015. 'Bottom-up and middle-down proteomics
have comparable accuracies in defining histone post-translational modification relative
abundance and stoichiometry', Analytical Chemistry, 87: 3129-33.
Sidoli, S., S. Lin, L. Xiong, N. V. Bhanu, K. R. Karch, E. Johansen, C. Hunter, S. Mollah, and B.
A. Garcia. 2015. 'Sequential Window Acquisition of all Theoretical Mass Spectra
(SWATH) Analysis for Characterization and Quantification of Histone Post-translational
Modifications', Mol Cell Proteomics, 14: 2420-8.
Sidoli, S., C. Lu, M. Coradin, X. Wang, K. R. Karch, C. Ruminowicz, and B. A. Garcia. 2017.
'Metabolic labeling in middle-down proteomics allows for investigation of the dynamics of
the histone code', Epigenetics Chromatin, 10: 34.
Sidoli, S., J. Simithy, K. R. Karch, K. Kulej, and B. A. Garcia. 2015. 'Low Resolution DataIndependent Acquisition in an LTQ-Orbitrap Allows for Simplified and Fully Untargeted
Analysis of Histone Modifications', Analytical Chemistry, 87: 11448-54.
Sidoli, S., S. Trefely, B. A. Garcia, and A. Carrer. 2019. 'Integrated Analysis of Acetyl-CoA and
Histone Modification via Mass Spectrometry to Investigate Metabolically Driven
Acetylation', Methods in Molecular Biology, 1928: 125-47.
Sivanand, S., I. Viney, and K. E. Wellen. 2018. 'Spatiotemporal Control of Acetyl-CoA Metabolism
in Chromatin Regulation', Trends in Biochemical Sciences, 43: 61-74.
Soreq, H., and S. Seidman. 2001. 'Acetylcholinesterase--new roles for an old actor', Nature
Reviews: Neuroscience, 2: 294-302.
Strahl, B. D., and C. D. Allis. 2000. 'The language of covalent histone modifications', Nature, 403:
41-5.
105

Sugiyama, H., K. Takahashi, T. Yamamoto, M. Iwasaki, M. Narita, M. Nakamura, T. A. Rand, M.
Nakagawa, A. Watanabe, and S. Yamanaka. 2017. 'Nat1 promotes translation of specific
proteins that induce differentiation of mouse embryonic stem cells', Proceedings of the
National Academy of Sciences of the United States of America, 114: 340-45.
Sutendra, G., A. Kinnaird, P. Dromparis, R. Paulin, T. H. Stenson, A. Haromy, K. Hashimoto, N.
Zhang, E. Flaim, and E. D. Michelakis. 2014. 'A nuclear pyruvate dehydrogenase
complex is important for the generation of acetyl-CoA and histone acetylation', Cell, 158:
84-97.
Sweetlove, L. J., and A. R. Fernie. 2018. 'The role of dynamic enzyme assemblies and substrate
channelling in metabolic regulation', Nat Commun, 9: 2136.
Sweredoski, M. J., A. Moradian, and S. Hess. 2017. 'High-Resolution Parallel Reaction
Monitoring with Electron Transfer Dissociation for Middle-Down Proteomics: An
Application to Study the Quantitative Changes Induced by Histone Modifying Enzyme
Inhibitors and Activators', Methods Mol Biol, 1647: 61-69.
Sweredoski, M. J., A. Moradian, M. Raedle, C. Franco, and S. Hess. 2015. 'High resolution
parallel reaction monitoring with electron transfer dissociation for middle-down
proteomics', Analytical Chemistry, 87: 8360-6.
Switzar, L., M. Giera, and W. M. Niessen. 2013. 'Protein digestion: an overview of the available
techniques and recent developments', Journal of Proteome Research, 12: 1067-77.
Takahashi, H., J. M. McCaffery, R. A. Irizarry, and J. D. Boeke. 2006. 'Nucleocytosolic acetylcoenzyme a synthetase is required for histone acetylation and global transcription',
Molecular Cell, 23: 207-17.
Thomas, J. O. 1999. 'Histone H1: location and role', Current Opinion in Cell Biology, 11: 312-7.
Tian, Z., N. Tolic, R. Zhao, R. J. Moore, S. M. Hengel, E. W. Robinson, D. L. Stenoien, S. Wu, R.
D. Smith, and L. Pasa-Tolic. 2012. 'Enhanced top-down characterization of histone posttranslational modifications', Genome Biology, 13: R86.
Trefely, S., K. Huber, J. Liu, M. Noji, S. Stransky, J. Singh, M. T. Doan, C. D. Lovell, E. von
Krusenstiern, H. Jiang, A. Bostwick, H. L. Pepper, L. Izzo, S. Zhao, J. P. Xu, K. C. Bedi,
Jr., J. E. Rame, J. G. Bogner-Strauss, C. Mesaros, S. Sidoli, K. E. Wellen, and N. W.
Snyder. 2022. 'Quantitative subcellular acyl-CoA analysis reveals distinct nuclear
metabolism and isoleucine-dependent histone propionylation', Molecular Cell, 82: 447-62
e6.
Tvardovskiy, A., K. Wrzesinski, S. Sidoli, S. J. Fey, A. Rogowska-Wrzesinska, and O. N. Jensen.
2015. 'Top-down and Middle-down Protein Analysis Reveals that Intact and Clipped
Human Histones Differ in Post-translational Modification Patterns', Mol Cell Proteomics,
14: 3142-53.
Van den Berg, M. A., and H. Y. Steensma. 1995. 'ACS2, a Saccharomyces cerevisiae gene
encoding acetyl-coenzyme A synthetase, essential for growth on glucose', European
Journal of Biochemistry, 231: 704-13.
van der Knaap, J. A., and C. P. Verrijzer. 2016. 'Undercover: gene control by metabolites and
metabolic enzymes', Genes Dev, 30: 2345-69.
von Gruning, H., M. Coradin, M. R. Mendoza, J. Reader, S. Sidoli, B. A. Garcia, and L. M.
Birkholtz. 2022. 'A dynamic and combinatorial histone code drives malaria parasite
asexual and sexual development', Mol Cell Proteomics: 100199.
Waddington, C. H. 2012. 'The epigenotype. 1942', International Journal of Epidemiology, 41: 103.
Waddington, C.H., and H. Kacser. 1957. The Strategy of the Genes: A Discussion of Some
Aspects of Theoretical Biology (Allen & Unwin).
Wang, T., M. V. Holt, and N. L. Young. 2018. 'The histone H4 proteoform dynamics in response
to SUV4-20 inhibition reveals single molecule mechanisms of inhibitor resistance',
Epigenetics Chromatin, 11: 29.
106

Weaver, I. C., A. C. Korgan, K. Lee, R. V. Wheeler, A. S. Hundert, and D. Goguen. 2017. 'Stress
and the Emerging Roles of Chromatin Remodeling in Signal Integration and Stable
Transmission of Reversible Phenotypes', Frontiers in Behavioral Neuroscience, 11: 41.
Wellen, K. E., G. Hatzivassiliou, U. M. Sachdeva, T. V. Bui, J. R. Cross, and C. B. Thompson.
2009. 'ATP-citrate lyase links cellular metabolism to histone acetylation', Science, 324:
1076-80.
West, C., C. Elfakir, and M. Lafosse. 2010. 'Porous graphitic carbon: a versatile stationary phase
for liquid chromatography', Journal of Chromatography A, 1217: 3201-16.
Xu, D., F. Shao, X. Bian, Y. Meng, T. Liang, and Z. Lu. 2021. 'The Evolving Landscape of
Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies', Cell
Metabolism, 33: 33-50.
Xu, M., J. S. Nagati, J. Xie, J. Li, H. Walters, Y. A. Moon, R. D. Gerard, C. L. Huang, S. A.
Comerford, R. E. Hammer, J. D. Horton, R. Chen, and J. A. Garcia. 2014. 'An acetate
switch regulates stress erythropoiesis', Nature Medicine, 20: 1018-26.
Yamanaka, S., X. Y. Zhang, M. Maeda, K. Miura, S. Wang, R. V. Farese, Jr., H. Iwao, and T. L.
Innerarity. 2000. 'Essential role of NAT1/p97/DAP5 in embryonic differentiation and the
retinoic acid pathway', EMBO Journal, 19: 5533-41.
Ye, C., and B. P. Tu. 2018. 'Sink into the Epigenome: Histones as Repositories That Influence
Cellular Metabolism', Trends Endocrinol Metab.
Young, N. L., P. A. DiMaggio, M. D. Plazas-Mayorca, R. C. Baliban, C. A. Floudas, and B. A.
Garcia. 2009. 'High throughput characterization of combinatorial histone codes', Mol Cell
Proteomics, 8: 2266-84.
Yuan, Z. F., A. M. Arnaudo, and B. A. Garcia. 2014. 'Mass spectrometric analysis of histone
proteoforms', Annual Review of Analytical Chemistry (Palo Alto, Calif.), 7: 113-28.
Yuan, Z. F., S. Lin, R. C. Molden, X. J. Cao, N. V. Bhanu, X. Wang, S. Sidoli, S. Liu, and B. A.
Garcia. 2015. 'EpiProfile Quantifies Histone Peptides With Modifications by Extracting
Retention Time and Intensity in High-resolution Mass Spectra', Mol Cell Proteomics, 14:
1696-707.
Yuan, Z. F., S. Sidoli, D. M. Marchione, J. Simithy, K. A. Janssen, M. R. Szurgot, and B. A.
Garcia. 2018. 'EpiProfile 2.0: A Computational Platform for Processing Epi-Proteomics
Mass Spectrometry Data', Journal of Proteome Research, 17: 2533-41.
Zhang, Y., and T. G. Kutateladze. 2019. 'Liquid-liquid phase separation is an intrinsic
physicochemical property of chromatin', Nature Structural & Molecular Biology, 26: 108586.
Zhao, Y., and B. A. Garcia. 2015. 'Comprehensive Catalog of Currently Documented Histone
Modifications', Cold Spring Harbor Perspectives in Biology, 7: a025064.
Zheng, Y., L. Fornelli, P. D. Compton, S. Sharma, J. Canterbury, C. Mullen, V. Zabrouskov, R. T.
Fellers, P. M. Thomas, J. D. Licht, M. W. Senko, and N. L. Kelleher. 2016. 'Unabridged
Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals
Hypermethylated Proteoforms from MMSET/NSD2 Overexpression', Mol Cell Proteomics,
15: 776-90.
Zheng, Y., X. Huang, and N. L. Kelleher. 2016. 'Epiproteomics: quantitative analysis of histone
marks and codes by mass spectrometry', Current Opinion in Chemical Biology, 33: 14250.

107

